Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
CACNG3		ENSG00000006116	Calcium voltage-gated channel auxiliary subunit gamma 3	O60359	16	24255553-24362801	Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	brain: 32.2	Cell type enriched	Detected in some	46	Horizontal cells: 166.8	Cancer enriched	Detected in single	15	glioma: 0.7	Group enriched	Detected in many	6	amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA077238	Enhanced											HPA077238: 					unprognostic (5.61e-2)						unprognostic (3.09e-1)			unprognostic (2.12e-1)	unprognostic (1.17e-1)			0.4	1.8	12.8	0.4	13.1	0.5	0.3	0.2	32.2	0.3	0.4	0.1	0	0.3	0.3	0.4	0.3	0.4	0.3	0.3	12.7	2.2	0.3	0.4	0.3	0.4	1.8	2.3	0.4	0.3	0.3	0	0.4	0.3	0.4	0.4	0.1	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.4	0.4	0.6	0	0	0.3	0	0.4	0.3	0	0	0	0.3	0.1	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0.1	0	0.1	0.1	0	0	1.3	0	0	0.5	0.1	0	0	0.1	0	0.2	0	0	0	1	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0.2	0	0.2	0	0	0.1	0	0	0	0.2	0.1	0	0	1.1	0	0.2	0.9	0.2	0.1	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0.3	0	0.1	0	0	0	12.8	13.1	0.2	20	12.7	2.2	1.8	2.3	0.3	0	0	0	0	0	0	3.1	0.4	0	0	0	0	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	166.8	0	0	0	2	0	0	0	0	0	0.3	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	Horizontal cells
ARHGAP44	KIAA0672, RICH-2, RICH2	ENSG00000006740	Rho GTPase activating protein 44	Q17R89	17	12789539-12991643	Predicted intracellular proteins	Exocytosis	GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.7;parathyroid gland: 33.8	Cell type enriched	Detected in many	6	Horizontal cells: 168.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HEK 293: 10.5;SK-BR-3: 8.0;SuSa: 14.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038814	Approved											HPA038814: AB_10673295	unprognostic (4.30e-2)	unprognostic (3.48e-1)	unprognostic (5.18e-3)	unprognostic (2.69e-2)	unprognostic (1.42e-1)	unprognostic (1.80e-1)	unprognostic (1.83e-1)	unprognostic (1.68e-2)	unprognostic (5.35e-2)	unprognostic (2.17e-1)	unprognostic (1.45e-2)	unprognostic (4.02e-2)	unprognostic (3.95e-2)	unprognostic (6.31e-3)	unprognostic (7.53e-3)	unprognostic (3.98e-1)	unprognostic (9.58e-2)	3.6	2.5	13.5	4.3	17.2	0.5	2	23.6	24.7	2.5	15.4	2.7	3.8	7.5	3.3	3.7	1.6	10.6	5.7	4.5	16.8	11.5	3.2	1	12.3	2	7.1	11.1	5.1	4.5	33.8	11.3	9.8	15.5	3.7	12.5	4.6	5.6	4.8	2.6	1.5	7.6	3.6	3.4	1.2	3.7	2.5	2.8	0	7.3	0	2	2.3	3.6	0.6	0	0	0.4	0.3	0.6	0	0.4	1.6	1.3	1	0.1	0.7	4.4	1	5.2	0.3	0.5	0.8	0.2	4.1	0.5	1.7	2.7	0.7	2.8	0	0.1	0.3	10.5	0.1	1.6	1.7	0.2	0	0.3	0.2	0.4	0.3	0	0	0	6.5	0.3	0	0	5.1	0.5	0.4	4.4	2.4	0.4	3.8	0.4	0.9	0.1	1.5	4.3	0.3	0.1	8	0.1	14.6	1.1	1.5	0	4.2	2.4	1.6	0.1	0	0	0.5	0.9	0.1	0.6	0	0	0	0.1	0.4	0.3	0.6	0.2	0.4	0	0.4	0.1	0	0	0.3	0	0	0.6	0	13.5	17.2	23.6	24.7	16.8	11.5	7.1	11.1	15.5	2.8	11.9	10.9	2	5.1	2.4	14.1	6.8	15.3	6.7	2.3	8.7	2	1.8	0	3.5	15.3	1.9	13.4	0	3.9	0.9	2.3	4	0	0.5	0.6	168.5	11.5	3.7	0.8	2.6	4	0	1.7	0	12.8	7.2	4.1	7	10.3	0.6	14.4	19.4	8	0.7	5.3	1.4	0.7	0	29.9	2.8	Horizontal cells
MARK4	FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D	ENSG00000007047	Microtubule affinity regulating kinase 4	Q96L34	19	45079288-45305283	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis	Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Horizontal cells: 112.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039186	Approved		Supported	Cytosol						Cytosol		HPA039186: AB_10796223	unprognostic (1.64e-1)	unprognostic (1.95e-1)	unprognostic (1.57e-3)	prognostic unfavorable (8.31e-8)	unprognostic (2.02e-1)	prognostic unfavorable (3.05e-5)	unprognostic (1.90e-1)	unprognostic (2.16e-2)	unprognostic (6.26e-2)	unprognostic (5.64e-3)	unprognostic (1.24e-3)	unprognostic (7.50e-2)	unprognostic (3.80e-2)	unprognostic (6.89e-2)	unprognostic (7.23e-2)	unprognostic (4.65e-2)	unprognostic (3.02e-2)	11.8	13	19.4	10.3	26	8.4	15.2	21.9	28.6	11.4	10.2	9	12.9	6.6	14	17.5	13.5	12.9	13.4	14.7	22.2	15.7	8.7	13.5	11.7	10.5	14.3	21.6	21	16.8	13.7	12.9	12.1	15	12.2	6.3	14.1	12.1	14.2	40.7	20.6	7.5	14.1	10.8	12.4	10.3	32.1	12.3	11.2	10.5	11.5	9.4	13.7	17.9	1	2.8	3.5	2.9	1.8	4.3	1.2	8.9	3.8	15.1	11	10.8	17.2	4.2	6.6	10.4	9.9	9.3	2.3	5.1	4.3	5.7	12.1	8.2	6.1	10.7	9.7	5.6	7.9	8.8	8.6	4.7	8.2	19.9	2.1	7.5	21.4	13.8	8.3	9.6	17.5	13.2	9.6	10.9	10.8	10.7	7.5	7.6	6.7	6.5	7.4	3.3	29.6	4.9	2.8	9.3	7.2	28.4	12.5	9.8	8.7	5.1	15.3	4.1	12.5	10.7	8.9	6.8	6	4.3	12.1	9.6	4.9	9.5	4	7.1	3.5	2.9	0.7	3.4	2.2	0.7	0.9	1.2	4.3	0.8	1	2.3	2.6	2.9	1.8	2	2.8	2.4	1.2	19.4	26	21.9	22.7	22.2	15.7	14.3	21.6	15	12.3	11.9	1.9	3	9.5	22.1	20.9	7.3	10.2	0	2.3	8.7	23.6	3.3	10	7.8	2.1	10.5	3.3	0	5.3	1.1	7.5	8.5	2.3	10.9	5.8	112.8	5.8	18.4	8.4	4.1	15	6.1	3.3	2.8	6	13.2	7.3	3.2	13.1	5.6	14.6	0	7.3	0.5	6.1	21.1	9.6	6.9	3.4	14	Horizontal cells
TFAP2B	AP2-B	ENSG00000008196	Transcription factor AP-2 beta	Q92481	6	50818723-50847613	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	epididymis: 65.5	Cell type enriched	Detected in some	4	Horizontal cells: 413.2	Cancer enriched	Detected in some	8	breast cancer: 12.1	Group enriched	Detected in some	41	cerebellum: 4.7;pons and medulla: 6.3	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	AF22: 32.4;SH-SY5Y: 60.4	Region enhanced	Detected in some		cerebellum: 11.2	Low region specificity	Detected in many			HPA034683, HPA062942	Enhanced		Approved	Nucleoplasm						Nucleoplasm		HPA034683: AB_10670966, HPA062942: AB_2684909	unprognostic (2.02e-1)	unprognostic (2.29e-2)		unprognostic (4.27e-2)	unprognostic (5.88e-4)	unprognostic (9.76e-2)		unprognostic (2.10e-1)	unprognostic (1.00e-1)			unprognostic (4.57e-1)	unprognostic (6.58e-6)	unprognostic (1.13e-2)	unprognostic (1.88e-1)		unprognostic (7.17e-3)	0.2	3	0	0	0	0	9.4	4.7	0	0.2	0.2	0	8.8	0	0	65.5	5.8	0	0	0.1	0	0.1	6.2	0	0	0	0.1	0	0	0	0	0.7	0.2	6.3	0.1	0	12.2	7	0.6	0	6.3	0	0	1.1	0	0	1.5	0	0	0	0.3	0	0.1	0.3	0	0	0	0	0	0	0	0	0	32.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	11.5	0	0	60.4	0	0.2	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.7	0	0	0.1	0.1	0	6.3	0	0	0	0	0	10.4	6.9	0.6	0	0	0	48.8	7.9	10.5	46.4	0	11.5	0.3	0	0	0	3.7	0.3	0	0	0	1	413.2	0	0	0	0.5	0	0	101.3	0	0	2.3	0	0	0.4	0.7	9.7	0	0	0.5	0	3.8	4.1	0	0	0	Horizontal cells
RPS6KA2	HU-2, RSK, RSK3	ENSG00000071242	Ribosomal protein S6 kinase A2	Q15349	6	166409364-166906451	Enzymes, Plasma proteins, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase	Tumor suppressor	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Horizontal cells: 271.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in some	4	eosinophil: 17.5	Lineage enriched	Detected in many	4	granulocytes: 17.5	Cell line enhanced	Detected in many		ASC diff: 48.4;ASC TERT1: 35.5;HHSteC: 35.9;HSkMC: 31.9;hTERT-HME1: 38.6;hTERT-RPE1: 70.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB026243, HPA045061, HPA054237, CAB069428	Approved		Supported	Nucleoplasm						Nucleoplasm		CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425	unprognostic (8.71e-2)	unprognostic (3.14e-3)	unprognostic (7.29e-2)	unprognostic (1.72e-1)	unprognostic (3.80e-1)	unprognostic (2.45e-1)	unprognostic (6.44e-3)	unprognostic (8.63e-2)	unprognostic (1.40e-1)	prognostic unfavorable (8.63e-5)	unprognostic (8.68e-2)	unprognostic (4.11e-2)	prognostic favorable (2.86e-5)	unprognostic (3.12e-3)	unprognostic (1.51e-1)	unprognostic (1.56e-2)	unprognostic (2.01e-1)	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14	11.9	12.5	40.9	25	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18	12.1	22.7	10.6	7.4	11.1	9	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	1.9	0	3.9	5.7	48.4	35.5	0	4.1	8.1	2.3	3.2	0	1.2	0.2	1.3	14.6	1.8	1.7	2	9	2.1	0.8	0.5	0	8.5	0.1	35.9	0.1	1.6	31.9	6.5	12.5	38.6	70.4	12.6	4.1	0	0	9.5	0.4	0.1	0.4	1	1.9	2.3	0.6	2	5.7	2.4	2.1	2.1	15.2	1.4	3.9	5.3	1	0.1	3	4.6	8.3	0.8	22.8	1.2	1.1	1.7	0.5	5.5	0.2	7.8	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25	18.3	22.4	18.4	22.7	25.7	20.8	34.5	0	4.1	4.1	34.9	54.9	22.9	2.7	13.6	34.9	7.9	0.1	10	12.8	12	47.2	0.5	0	20.9	0.2	8	9.4	2.3	11.6	7.2	271.7	5.2	38.6	5	48.4	4.9	4.7	18.6	3.6	5.5	8.3	22.7	1.4	4.2	4.4	15.4	12.9	6.9	3.2	1.1	3	0.2	1.3	1.2	5.8	Horizontal cells
CACNG5		ENSG00000075429	Calcium voltage-gated channel auxiliary subunit gamma 5	Q9UF02	17	66835117-66885486	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	6	brain: 6.5;lymphoid tissue: 3.3;retina: 8.8	Cell type enriched	Detected in single	17	Horizontal cells: 4.8	Cancer enhanced	Detected in single		glioma: 0.5	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 1.7;RPMI-8226: 1.5;SH-SY5Y: 3.6;SuSa: 1.3;THP-1: 1.6	Region enhanced	Detected in all		olfactory region: 152.3	Low region specificity	Detected in all			HPA050115	Uncertain											HPA050115: AB_2681022					unprognostic (1.85e-3)					unprognostic (3.84e-2)	unprognostic (1.44e-1)		unprognostic (2.46e-6)	unprognostic (4.52e-2)	unprognostic (1.29e-1)			0.3	0.3	2.7	0.7	2.6	0.3	0.3	1.7	6.5	0.4	0.7	6.3	0	0.3	0.3	0.3	0.3	0.3	0.3	0.4	2.1	2	1	0.3	0.3	3.3	1.1	2.3	0.3	0.7	0.3	0.8	0.3	0.7	0.5	0.5	8.8	0.3	0.3	0.3	0.4	0.7	0.3	1.7	1.3	0.3	0.7	3.8	0	0.3	0	3.2	0.3	0.1	0	0	0	0	0	0	0	0	0.7	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	1.7	0	0	0	0	1.5	0	0	0.4	3.6	0	0	0	1.3	0	1.6	0	0	0.7	0	0	0	0	0.5	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	2.6	1.7	6.5	2.1	2	1.1	2.3	0.7	3.8	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Horizontal cells
PLXNA2	FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2	ENSG00000076356	Plexin A2	O75051	1	208022242-208244320	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		pancreas: 39.9	Cell type enriched	Detected in many	6	Horizontal cells: 235.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		BEWO: 18.8;HaCaT: 19.3;HUVEC TERT2: 24.6;TIME: 56.5	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB009763	Approved								580000			CAB009763: AB_2166388	unprognostic (8.25e-2)	unprognostic (3.91e-2)	unprognostic (8.85e-2)	unprognostic (2.77e-2)	unprognostic (8.66e-2)	unprognostic (2.07e-1)	unprognostic (1.97e-2)	unprognostic (4.84e-2)	unprognostic (6.88e-3)	unprognostic (7.06e-2)	unprognostic (2.61e-1)	unprognostic (8.41e-2)	unprognostic (4.49e-3)	unprognostic (1.26e-1)	unprognostic (5.40e-2)	unprognostic (1.27e-2)	unprognostic (2.40e-1)	7.2	2.4	8.3	2.9	11.8	1	3.9	27.5	14.7	4.7	10.5	2.5	2	8.2	5.4	3	13.2	4.6	7	6	9.7	4	4.3	2.7	12	1.6	3.7	10.9	16.9	39.9	2	2.8	10.2	6.7	4.2	8.8	5.7	3.7	4.5	7.6	10.8	9	12	2.9	1.7	11	1.2	3.9	0.4	7.2	4.7	4.4	8.3	9.1	0.2	0.7	1.1	0.7	0	0.4	0.2	2.1	1.3	2.4	0.3	2.7	5.4	18.8	1.7	1.1	1	0.1	0	0	0	3.5	1.3	0.4	19.3	0	10.9	0.3	0.6	0.3	0	2.3	1.2	1.1	0	0	1.4	3.5	0.8	5.1	0.7	24.6	0	0	0	10.7	0.2	0	0	0.3	3.8	3.3	0	2.5	1.6	2	1.3	0.7	4.4	2	1.6	2	4.9	0.1	0	56.5	0.4	0.6	2	3.5	0.1	0	0	2.3	0	0.9	0	0.7	1.1	0.2	0.2	0.3	0	0	0.2	0.7	0.2	0	0.4	1	0	0.3	0	0	0.2	8.3	11.8	27.5	14.7	9.7	4	3.7	10.9	6.7	3.9	26.8	25.8	2	10.2	4.2	1	3.9	10.2	12	39.8	0	2	5	1.7	3.6	0.6	31.8	40.9	0	13.3	2.1	9.8	4.5	5.8	4.9	2.5	235.2	8.7	29.4	3.5	0	9.2	2.2	5	1	27.3	0.3	17	37.7	6.3	1.1	2.5	6.5	5.9	0.6	0.6	9.3	1.6	1	24.2	22.6	Horizontal cells
FAM135A	FLJ20176, KIAA1411	ENSG00000082269	Family with sequence similarity 135 member A	Q9P2D6	6	70412941-70561174	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Horizontal cells: 225.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		RH-30: 24.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031743, HPA031744	Approved		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA031743: AB_10600767, HPA031744: AB_10601101	unprognostic (5.79e-2)	unprognostic (1.64e-1)	prognostic favorable (8.00e-4)	unprognostic (1.59e-1)	unprognostic (1.66e-2)	unprognostic (1.08e-1)	unprognostic (6.69e-4)	unprognostic (4.08e-2)	unprognostic (3.87e-2)	unprognostic (1.58e-1)	unprognostic (1.02e-1)	unprognostic (1.41e-1)	prognostic favorable (3.46e-4)	unprognostic (3.99e-1)	unprognostic (2.75e-1)	unprognostic (6.26e-2)	unprognostic (2.65e-2)	5.8	4.3	6.4	9.2	6.8	1.7	5.3	14	10.7	9.6	13.3	4	5.3	14.9	7.7	4.9	33.8	5.4	8.8	5.2	5.4	5.2	9.6	5.5	5.5	4.1	6.1	7.1	8	6.9	16.4	13.8	22.7	8.5	18.9	13	4.2	10.4	6.7	5.7	14.2	27.9	4.8	8.9	4.5	12.3	11	6	4.1	4.8	13.1	10.6	7.6	14.4	3.9	6.3	3.3	5.3	5.4	2.2	1.5	5.9	3.4	7.7	4.8	3.6	2.6	6.9	1.9	3.8	2.1	3.5	6.7	4.8	10.6	13.9	1.4	10.1	5.8	7.6	4.8	3.6	5.1	6.3	4.8	3.7	5.9	4.4	8.9	5	2.3	11.1	4	11.1	2.6	5.5	3.4	7.6	5.5	2.4	0.7	1.6	4.2	5	7.1	2.8	5.2	24.2	5	7.9	3.2	8.1	2.4	2.3	2.1	2.3	5.1	1.4	4	2.7	1.8	4.6	1.7	4.4	6.6	7.5	4.3	1.3	8.1	3.2	3.3	4.3	0.2	1.5	3.5	1.9	3	1.4	0.6	6.3	3.9	2.2	1.3	1.2	5.4	5.3	1	1.7	1.5	6.4	6.8	14	10.7	5.4	5.2	6.1	7.1	8.5	6	26.8	12.2	1.4	9.5	14.2	18.2	9.4	15.3	8.1	5.7	19.2	27.5	2.2	5	5.8	24.9	10	28.4	0	10.7	1.2	5.9	32.9	8.1	5.7	5.1	225.6	22.4	9.2	14.2	17.3	14.4	13.1	5	9	26.1	12.8	13.3	30	12.4	6.8	27.5	6.5	6.6	25.1	8.2	29.4	6.9	3.9	19.4	11.2	Horizontal cells
SEZ6L		ENSG00000100095	Seizure related 6 homolog like	Q9BYH1	22	26169474-26383597	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 60.8	Cell type enriched	Detected in some	6	Horizontal cells: 20.6	Group enriched	Detected in some	6	glioma: 14.6;pancreatic cancer: 3.7	Low region specificity	Detected in all			Group enriched	Detected in some	6	intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3	Group enriched	Detected in many	73	dendritic cells: 7.2;monocytes: 7.4	Group enriched	Detected in some	7	SCLC-21H: 30.8;SH-SY5Y: 8.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA045135			Approved	Vesicles					2400000	Vesicles		HPA045135: AB_2732518	unprognostic (1.01e-2)	unprognostic (1.03e-1)	unprognostic (1.37e-1)	unprognostic (4.95e-2)	unprognostic (4.49e-2)	unprognostic (6.47e-2)	unprognostic (4.19e-1)	unprognostic (1.09e-2)	unprognostic (5.02e-2)	unprognostic (7.22e-2)	unprognostic (1.39e-3)	unprognostic (7.80e-2)	unprognostic (2.40e-6)	unprognostic (4.52e-2)	unprognostic (3.89e-1)	unprognostic (2.39e-4)	unprognostic (3.18e-1)	1.2	12.5	26.4	1.6	11.3	1.3	1.1	20.1	60.8	2.4	1.3	4.3	0	1.5	1.1	1.1	1.1	1.1	1.2	2.5	39.1	23.6	1.1	1.1	1.3	1.1	11.2	25.5	1.1	2.7	1	3.8	1.1	15	1.3	1.4	0	1.3	1.2	1.1	1.2	1.6	1.4	5.3	1.3	2.9	1.4	5.4	0	1.2	0	1.1	1.2	0.2	0	7.2	0	7.4	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	30.8	8.2	0	0	0	0.2	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	1.1	0	0	7.4	0	0	0	0	7.2	0	0	0	0	0	6.3	0	0	0.5	26.4	11.3	20.1	29.3	39.1	23.6	11.2	25.5	15	5.4	0	0	0	0	0.1	0.7	0.8	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0.1	0	0	0.3	20.6	0	0	0	0.7	0.6	0.7	0	3.6	0	0.5	1	0	0.4	0	0.7	0	0	0.2	0	0.1	0	0	0	0	Horizontal cells
SALL4	dJ1112F19.1, ZNF797	ENSG00000101115	Spalt like transcription factor 4	Q9UJQ4	20	51782331-51802520	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding	Cancer-related genes, Disease mutation, Oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6	Cell type enriched	Detected in some	7	Horizontal cells: 25.4	Cancer enriched	Detected in many	11	testis cancer: 22.7	Not detected	Not detected			Cell type enriched	Detected in single	9	NK-cell: 6.3	Lineage enriched	Detected in single	9	NK-cells: 6.3	Cell line enhanced	Detected in some		AF22: 13.1;AN3-CA: 9.1;BEWO: 17.5;NTERA-2: 31.5;SiHa: 8.0;SuSa: 22.0	Not detected	Not detected			Low region specificity	Detected in all			HPA015291, HPA015791	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		HPA015291: AB_1856548, HPA015791: AB_1856547	unprognostic (1.30e-1)	unprognostic (2.35e-2)	unprognostic (1.11e-1)	unprognostic (1.09e-3)	unprognostic (3.55e-2)	unprognostic (7.43e-2)	unprognostic (3.63e-2)	unprognostic (1.47e-1)	unprognostic (1.20e-1)	unprognostic (9.23e-2)	unprognostic (2.50e-2)	unprognostic (2.39e-2)	unprognostic (2.42e-8)	unprognostic (5.90e-3)	unprognostic (1.82e-1)	unprognostic (5.00e-5)	unprognostic (7.41e-2)	0.3	0.4	0.3	0.3	0.9	1.2	0.3	0.8	0.9	0.4	0.7	0.3	2.2	0.1	0.3	0.8	0.3	0.2	0.3	0.3	0.3	0.1	0.5	1.9	0.3	0.3	0.3	0.3	0.3	4.6	8.8	0.6	0.3	0.9	3.1	0.2	4.5	2.2	0.4	0.3	0.3	0.7	0.3	0.3	0.8	0.3	11.7	0.3	0.3	8.6	0.3	0.3	0.9	0.3	0.1	0.1	0.6	0.1	6.3	0.2	0	0	0.8	13.1	9.1	0	0	17.5	0	0.1	0	0.1	4.5	0.1	0	0.1	0.1	0.1	2.2	0.1	0	0.1	0.2	0	0	3	0.2	0.1	0	1	0.4	0.2	0	0	0	0.2	0	0	0	0	0.9	0	0	31.5	0.1	0.2	1.2	0	0	0	0.2	3	1.6	8	0	0.7	22	0	0.5	0	0.5	1.8	0.2	0	0	0	0	0	0	0.1	0.2	0	0	0.2	0	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.6	6.3	0.1	0.1	0	0	0.3	0.9	0.8	0.9	0.3	0.1	0.3	0.3	0.9	0.3	0	1.3	0	0.7	0	0.1	0.3	0	0	0	0	0	0	0	3.5	0	0	0	0	0.2	0	0.4	1.1	0	0	0.2	25.4	1.2	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.4	0	0	0.5	1.7	0	0	0	0	1	Horizontal cells
CHRNA4	BFNC, EBN, EBN1	ENSG00000101204	Cholinergic receptor nicotinic alpha 4 subunit	P43681	20	63343223-63378401	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	brain: 16.4;liver: 38.8;parathyroid gland: 21.6	Cell type enriched	Detected in some	5	Horizontal cells: 131.9	Cancer enhanced	Detected in some		liver cancer: 1.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	U-2 OS: 7.6	Low region specificity	Detected in many			Group enriched	Detected in many	5	midbrain: 22.6;pons and medulla: 19.3;thalamus: 29.6	CAB034064	Uncertain											CAB034064: AB_2080535	unprognostic (3.40e-1)	unprognostic (1.71e-1)		unprognostic (2.87e-2)	unprognostic (3.98e-1)	unprognostic (8.03e-2)	unprognostic (1.75e-1)	unprognostic (1.22e-1)	unprognostic (1.74e-1)	unprognostic (2.10e-3)	unprognostic (5.72e-4)	unprognostic (9.02e-3)	unprognostic (9.79e-4)	unprognostic (6.77e-2)	unprognostic (1.08e-1)	unprognostic (3.81e-2)		0.6	0.8	5.2	0.6	8.7	0.6	0.6	3.1	14.5	0.6	0.6	11	0	0.6	0.6	0.6	0.6	2	0.6	0.6	5.1	6.8	2.1	38.8	0.7	0.6	11.3	8.2	0.7	0.6	21.6	1	0.6	16.4	1.3	0.6	5.7	0.6	0.6	0.6	0.6	0.6	0.6	3.9	4.8	0.6	1.9	3.9	0	1.2	0	0.6	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.2	8.7	3.1	14.5	5.1	6.8	11.3	8.2	16.4	3.9	0	0	0	0	0	20.2	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25.2	0	131.9	0	0	1	1	0	0	0	0	0	0.8	0	0	0	2.8	2.3	0	0	0	1.2	0	0	0	0	0	Horizontal cells
SLC32A1	bA122O1.1, VGAT, VIAAT	ENSG00000101438	Solute carrier family 32 member 1	Q9H598	20	38724462-38729372	Predicted membrane proteins, Transporters	Neurotransmitter transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	brain: 38.3	Cell type enriched	Detected in some	14	Horizontal cells: 55.6	Cancer enhanced	Detected in single		glioma: 1.0	Low region specificity	Detected in all			Cell type enriched	Detected in single	20	plasmacytoid DC: 1.9	Lineage enriched	Detected in single	20	dendritic cells: 1.9	Group enriched	Detected in some	12	MOLT-4: 5.5;SH-SY5Y: 1.7	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB037156, HPA058859, HPA059985	Enhanced	Supported										CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187					unprognostic (1.13e-2)					unprognostic (2.09e-1)				unprognostic (1.17e-1)	unprognostic (6.57e-2)			1	1.1	4.6	1	38.3	1.5	1	4.9	25.8	1	1	0.8	0	1	1	1	1	1.1	1	1	3.9	9.7	1	1	1	1	4.4	6.8	1	1.1	1	4.1	1	10.4	1	1	0.7	1	1	1	1	1.1	1	4.4	1	1	1.6	7.9	0	1	0	1	1	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	4.6	38.3	4.9	11.9	3.9	9.7	4.4	6.8	10.4	7.9	0	0	0	0	0	1.3	0.3	0	0	0	0	3.9	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	55.6	1.7	0	0	0	0	0	0	0	0	0.9	0	0	0	0	3.1	0	0	0.9	0.4	0	0	0	0	0	Horizontal cells
SMPD3	NSMASE2	ENSG00000103056	Sphingomyelin phosphodiesterase 3	Q9NY59	16	68358325-68448688	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Cell cycle, Lipid metabolism, Sphingolipid metabolism	Developmental protein, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0	Cell type enriched	Detected in many	6	Horizontal cells: 284.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in some	7	plasmacytoid DC: 44.5	Lineage enriched	Detected in many	7	dendritic cells: 44.5	Cell line enhanced	Detected in some		HMC-1: 9.6;MOLT-4: 13.6;RPMI-8226: 11.3;SCLC-21H: 13.1	Region enhanced	Detected in many		basal ganglia: 103.1	Low region specificity	Detected in all			CAB033885, HPA065535, HPA069383	Approved		Supported	Endoplasmic reticulum						Endoplasmic reticulum		CAB033885: AB_1126788, HPA065535: , HPA069383: 	unprognostic (1.21e-1)	prognostic favorable (7.72e-4)	unprognostic (5.61e-3)	prognostic favorable (3.86e-4)	unprognostic (2.46e-1)	unprognostic (5.85e-4)	unprognostic (7.87e-2)	unprognostic (8.12e-3)	unprognostic (2.77e-2)	unprognostic (1.30e-1)	unprognostic (1.75e-1)	unprognostic (1.81e-1)	unprognostic (1.04e-3)	unprognostic (5.02e-3)	unprognostic (2.49e-1)	unprognostic (1.19e-1)	unprognostic (1.93e-3)	3.5	2.3	6	3.1	18.3	1.8	1.6	9.4	15.4	1	9.6	2.5	0	46.4	1.7	0.7	1.8	2.7	17.2	1.2	8.7	3.6	0.9	3.8	2.1	3.5	2.5	5	2.7	1.9	0.7	10.7	0.8	3.9	2.2	5.8	4.3	2.2	0.9	1.8	8.1	42.7	1.2	1.4	3	18.6	4.2	4.4	73	1.3	1.3	4.3	1.6	1.2	0.6	44.5	6.1	0	0	0.7	0.3	0.3	0.7	0.3	0.1	0	0	5.3	0.4	0	0.4	0.1	2.9	0.9	0.4	0.5	0.2	0.2	1.1	0	0	0.1	0.3	0.7	0.1	2.1	0.3	0	0	9.6	0	0	0	0.2	0.5	0	0.9	0.8	0.3	0.3	0.2	13.6	2.6	0.6	4.6	0.1	0.6	0.2	11.3	0	0.1	13.1	2.6	0.4	1.5	0.6	0.3	1	0.9	0	0.4	0.8	1.4	0.1	2.2	1.1	0.2	0.2	0.9	0.2	1	0	6.1	0.7	0	0.1	0.6	0	0.2	0	0.2	0.2	0.1	0	0	0	44.5	0.5	0.3	6	18.3	9.4	15.4	8.7	3.6	2.5	5	3.9	4.4	3	0.6	0	1.4	0.1	39.5	2.5	5.1	16	1.2	0	0	0	0	0.9	6	0	51.1	0	0.8	0.2	0.3	3.7	0	5	0.2	284.4	24.8	0	0.6	13	14.1	0	0	0	25.6	0.8	1.2	43	43.2	0	3.3	0	0	5.4	0.3	0.9	0	5	18.7	4.7	Horizontal cells
CACNG7		ENSG00000105605	Calcium voltage-gated channel auxiliary subunit gamma 7	P62955	19	53909335-53943941	Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	29	brain: 54.4	Cell type enriched	Detected in some	17	Horizontal cells: 127.1	Cancer enriched	Detected in some	16	glioma: 29.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 26.8;GAMG: 7.5;HMC-1: 20.9;hTERT-RPE1: 26.3;SH-SY5Y: 16.5	Low region specificity	Detected in all			Low region specificity	Detected in all																			unprognostic (3.11e-2)	unprognostic (7.18e-2)	unprognostic (6.24e-2)				unprognostic (3.06e-1)	unprognostic (1.24e-1)		unprognostic (1.01e-5)	unprognostic (1.51e-1)	unprognostic (7.36e-2)			1.2	1.8	22.2	1.3	15.6	1.2	1.2	22.7	54.4	1.2	1.3	8.3	0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	21.4	13.7	1.2	1.2	1.3	1.2	16.5	10.3	1.2	1.3	1.2	1.8	1.2	9.9	1.2	1.2	0.3	1.2	1.3	1.2	1.2	1.4	1.3	13.5	1.2	1.3	1.5	4.5	0	1.2	0	1.2	1.2	0	0	0	0	0	0	0	0	0	3.5	26.8	0	0.1	0	0	0.1	0	0	0	0	0	0	0.1	0	7.5	0	2.5	0	0	0	0	0	0	0	1.4	0	20.9	0.2	0	0	0	26.3	0.4	0	0	0	0	0	0	0	7.1	0	0	0	0	0	0	0	0	16.5	0	0	0	0.2	0	0	0	0.2	5.7	0	0	0	1.6	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.2	15.6	22.7	25.9	21.4	13.7	16.5	10.3	9.9	4.5	0	0	0	0	0	7.4	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	127.1	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	1.9	0	0	0.4	0.1	0	0	0	0	0	Horizontal cells
CRHR2	CRF-RB, CRF2, HM-CRF	ENSG00000106113	Corticotropin releasing hormone receptor 2	Q13324	7	30651943-30700129	G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 11.7	Cell type enriched	Detected in single	13	Horizontal cells: 12.7	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 1.3;HeLa: 1.8;NTERA-2: 3.0;SCLC-21H: 1.7	Low region specificity	Detected in many			Low region specificity	Detected in all								Secreted - unknown location								unprognostic (7.14e-2)	unprognostic (4.20e-1)	unprognostic (1.68e-1)	unprognostic (1.24e-3)	unprognostic (5.69e-2)	unprognostic (8.58e-2)	unprognostic (6.00e-2)	unprognostic (1.86e-4)	unprognostic (2.01e-1)	unprognostic (3.07e-1)	unprognostic (5.90e-4)	unprognostic (4.02e-2)	unprognostic (8.29e-4)	unprognostic (3.73e-3)	unprognostic (2.84e-3)	unprognostic (1.81e-1)	unprognostic (3.84e-1)	1.4	0.7	0.9	0.5	4.1	0.4	1.6	0.5	11.7	0.8	0.6	0	3.6	2.1	1.1	0.5	1.7	2.1	1	3.2	4.3	3.2	0.8	0.4	0.6	0.6	0.9	3.2	1	3.9	0.9	8	0.4	3.1	0.9	0.9	1.7	0.7	6.2	5.5	0.8	1.2	1.1	0.8	0.3	1	1.8	1	0	1.7	3.2	0.6	0.9	0.5	0	0	0	0	0	0.3	0	0.1	0.1	0.1	0.7	0	0	0	0.3	0	0	0.2	0.1	0	0.5	0	0	0.1	0.2	0.1	0	0	0.2	1.3	0	1.8	0	0	0.4	0.2	0	0	0	0	0	0	0.6	0.1	0.3	0	0	0.2	0.2	3	0	0.4	0	0	0.6	0	0.9	1.7	0.1	0.2	0	0.2	0.6	0.1	0	0.5	0.4	1	0.3	0.2	0.8	0.3	0	0.2	0.1	0.4	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	4.1	0.5	11.7	4.3	3.2	0.9	3.2	3.1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	12.7	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	Horizontal cells
NCS1	FREQ, NCS-1	ENSG00000107130	Neuronal calcium sensor 1	P62166	9	130172578-130237304	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 76.8	Cell type enriched	Detected in many	5	Horizontal cells: 106.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 1.2;MAIT T-cell: 1.2	Lineage enriched	Detected in single	13	T-cells: 1.2	Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB018587, HPA019713	Enhanced	Supported	Enhanced	Plasma membrane						Plasma membrane		CAB018587: AB_649907, HPA019713: AB_1854404	prognostic unfavorable (5.40e-4)	unprognostic (1.57e-1)	unprognostic (4.64e-3)	prognostic unfavorable (8.69e-4)	unprognostic (1.29e-1)	unprognostic (9.23e-2)	prognostic unfavorable (1.11e-4)	unprognostic (1.61e-3)	unprognostic (4.27e-1)	unprognostic (1.21e-2)	unprognostic (8.45e-2)	unprognostic (1.58e-1)	unprognostic (3.71e-3)	unprognostic (8.59e-2)	unprognostic (1.69e-1)	prognostic unfavorable (8.25e-4)	unprognostic (1.65e-1)	5.8	12.6	76.8	7.9	56.6	4.6	2.8	18.6	66.2	7.7	20.1	6.4	5	3.6	12.6	4.1	24.9	13.5	8.7	4.6	74.3	25.7	8.7	1.6	2.5	1.6	20.6	28.1	4.6	3.5	1.5	2.7	1.6	17.7	14.9	6.8	4.2	5.3	41.6	0.9	10	4.3	34.3	6.8	1.1	5.1	2.2	7.1	0	20.1	0.7	2.7	16.4	4.6	0	0	0	0	0	1.2	0.1	7.8	16	8.3	16.6	5.2	11.7	4	20.3	9.4	15.6	10.4	7.6	4	0	7.4	25.6	18.3	14.2	13.5	17.8	7	23.2	4.1	0	10.6	8.1	8	0.7	9.8	13.6	9.1	17.6	11.2	13.9	14.7	3.1	5.7	0.1	22.5	22.6	1.4	7.8	12.7	4.2	6.7	0	26.3	5.4	15.2	5	22	20.7	12.5	6	12	6.6	11.1	5	11.5	30.3	24.7	24.3	26	0	0	0	35.4	2.2	32.6	0	0	0	1.2	0	1.2	0	0	0.9	0	0	0	0	0	0	0	0	0	0.1	76.8	56.6	18.6	59.9	74.3	25.7	20.6	28.1	17.7	7.1	0	0	0	8.5	8.7	2.7	3.6	0	5.3	7.9	10.4	3.9	0	5	6.6	0.3	0	0	0	2.5	1.5	7.1	4.5	3.5	0	3.6	106.5	1.2	1.3	0	0	1.1	2.3	5	17.2	0.5	18.7	4.9	0	1.4	12.4	3.1	0	20.2	0	0.9	6	0.5	0	0	2.6	Horizontal cells
APBA1	D9S411E, MINT1, X11	ENSG00000107282	Amyloid beta precursor protein binding family A member 1	Q02410	9	69427530-69672306	Predicted intracellular proteins	Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 21.7	Cell type enriched	Detected in many	5	Horizontal cells: 65.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 7.1;BJ hTERT+: 6.0;HAP1: 17.1;SCLC-21H: 6.7;TIME: 7.7;U-138 MG: 7.1;U-266/70: 7.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA061287			Supported	Golgi apparatus						Golgi apparatus		HPA061287: AB_2684467	unprognostic (4.02e-2)	unprognostic (4.64e-2)	unprognostic (7.29e-2)	unprognostic (8.94e-3)	unprognostic (1.06e-1)	unprognostic (1.53e-1)	unprognostic (4.21e-3)	unprognostic (8.49e-3)	unprognostic (2.22e-1)	unprognostic (2.33e-1)	unprognostic (2.46e-5)	unprognostic (1.60e-1)	unprognostic (3.09e-2)	unprognostic (4.99e-3)	unprognostic (3.14e-2)	unprognostic (2.28e-1)	unprognostic (4.66e-3)	2.9	2.9	20.2	1.8	18.6	0.6	4	15.5	21.7	4.2	4.1	6.2	0.6	1.7	4	1.2	3.4	2.6	3	2.9	16	19.3	2.3	8.7	1.9	1.6	19.1	13.7	7.5	2.9	14.5	3.5	3.1	15.7	2.2	4.2	2.7	5.5	2.8	4	3.8	2.1	2.2	5.5	6	1.7	3.5	6.7	0	1.5	0.6	1.2	2.4	2	0	0.1	0.1	0.7	0	0.1	0	0	0	0.6	0	3.1	2.3	0.1	7.1	6	0.1	0.1	0	0	0	3.3	2.9	0	0.1	17.1	0	0	0	0.1	0	0	0	0.4	0	0	0.7	0	0	0	0.1	0.9	0.3	0	0	2.9	0.1	0	0	0.5	0.1	0	0	0.3	0	0	2.5	6.7	4.4	0.4	0.9	0.1	0.2	0	0	7.7	7.1	0.8	0	0.5	7.1	3.1	0	0.2	0.1	0.7	0	0.1	0	0	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0	0.7	0.1	0	0	20.2	18.6	15.5	19.7	16	19.3	19.1	13.7	15.7	6.7	0	0	0	1.2	1.5	12.7	3.9	0	0	0	0	3.9	0.7	0	0.1	0.1	0.7	0	0	0	0.4	0.6	0.4	0	2.8	2.4	65.2	4.1	3.1	2.5	0	2.3	0.7	0	1	1.5	3.9	0.2	0	10.3	0.4	9.6	0	1.4	0.9	1.3	2	0.3	0	0.8	0.4	Horizontal cells
SEPT4	ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2	ENSG00000108387	Septin 4	O43236	17	58520250-58540818	Predicted intracellular proteins	Cell cycle, Cell division, Differentiation, Spermatogenesis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 77.8;brain: 94.8	Cell type enriched	Detected in many	6	Horizontal cells: 2070.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		HHSteC: 11.0;hTERT-RPE1: 14.9;SK-MEL-30: 24.2	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB006855, HPA021587, HPA022905	Enhanced		Supported	Nucleoplasm						Nucleoplasm		CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687	unprognostic (1.12e-1)	unprognostic (5.54e-2)	unprognostic (8.36e-3)	unprognostic (8.01e-2)	unprognostic (1.19e-1)	unprognostic (2.96e-2)	unprognostic (6.88e-3)	unprognostic (2.73e-2)	unprognostic (2.76e-1)	unprognostic (8.02e-2)	unprognostic (1.97e-2)	unprognostic (2.10e-1)	prognostic unfavorable (3.28e-7)	unprognostic (6.40e-3)	unprognostic (1.58e-1)	unprognostic (8.26e-2)	unprognostic (8.75e-3)	14.8	77.8	70.5	2.6	80	0.9	7.2	44.3	82.7	4	3.3	92.4	0	2.7	3.5	3.9	3.2	2.7	8.3	14.3	84.8	49.9	8.5	25	9.5	5.9	94.8	32.3	5.4	3.9	4.8	2.4	9.9	49.7	2.5	3.1	10	4.4	3.8	4.2	3.9	2.9	6	84	18	2.8	7.3	56.5	0	4.5	0.5	3.8	5.1	1.3	1.7	5.5	2.9	5.5	1.4	7.6	5.6	0	0.4	0.9	2.6	1.1	0.1	0.4	0.1	0.3	1.6	1.9	0.1	0.1	0	3.9	0.6	2.4	0.2	1.4	1.1	0.4	0.1	0.7	0.9	0.2	5.5	11	0.1	0.5	5.7	2.2	0.4	2	14.9	0.5	1.4	0	2.6	0.1	0	0	0.1	0.5	0	0.7	0.1	0	1.2	0	0	2.8	1.6	0	0.1	24.2	1.3	0.4	0.3	0	0.1	1.2	0	1	0.8	0.4	0	0.9	0	0.3	0	5.5	1.1	7.6	0.7	2.4	1.7	1.6	2	5.5	0.6	2.9	2.3	2.9	1.4	0	0.3	1	5.6	70.5	80	44.3	50.5	84.8	49.9	94.8	32.3	49.7	56.5	0	0.6	0	0	5.5	93.8	45.3	0	0	0	7	329.9	3.6	14.9	0	62	12.7	0	23.3	0	0.3	7	0	1.1	20.8	4.7	2070.5	0	27.6	2.4	56.2	6.6	1.6	65.8	0	0	56.1	0	0	13.1	0.5	325.4	181.1	84.9	3.6	1.7	2.5	3.8	0	0	0	Horizontal cells
BACH2	BTBD25	ENSG00000112182	BTB domain and CNC homolog 2	Q9BYV9	6	89926529-90296908	Plasma proteins, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding, Repressor	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 29.8	Cell type enriched	Detected in many	4	Horizontal cells: 187.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in many	4	naive B-cell: 15.4	Lineage enriched	Detected in many	4	B-cells: 15.4	Group enriched	Detected in some	6	Daudi: 52.7;U-698: 30.9	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA051384, HPA058384	Enhanced		Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA051384: AB_2681462, HPA058384: AB_2683700	unprognostic (4.00e-3)	unprognostic (3.17e-2)	unprognostic (1.07e-1)	unprognostic (2.47e-4)	unprognostic (1.49e-1)	unprognostic (2.29e-1)	unprognostic (3.42e-2)	unprognostic (8.92e-2)	unprognostic (2.36e-1)	unprognostic (1.06e-2)	unprognostic (3.12e-3)	unprognostic (4.22e-1)	unprognostic (9.87e-3)	unprognostic (2.10e-2)	unprognostic (1.83e-1)	unprognostic (2.03e-1)	unprognostic (3.87e-4)	2.9	2.1	5.3	29.8	5.6	18.5	4.1	11.4	6.9	5.4	2.2	6.3	1	1.3	6.8	2.1	1.9	3	2.3	2.6	5.2	2.9	1.7	5.8	5.8	26.7	5.2	4	6.3	4	5.8	1.9	2.4	4.9	3.7	1.7	0.9	5.2	2.2	7.9	5.4	6.5	2.8	5.2	7.6	1.8	3.4	6.9	26.9	2	2.4	20.6	4.8	3.3	15.4	0.2	1.8	0	1.5	3.7	0.4	0.3	0	1.9	0.1	0.1	0	0.3	0	0.1	0	0.2	0	0	52.7	0	0	0	0	0.3	0.6	0.1	0	0.6	0	0	0	0	0	0.1	0.4	0.1	0	1.2	0	0	3.4	2.1	4.6	0	0.1	1	0	0.5	0	0.4	7.2	1.3	0.9	0	0.1	1.7	4.9	0.1	0	0.3	0.6	0	0	0.1	0	0.7	0	0	3.5	0.1	30.9	0.2	0.5	0.4	1.8	0	0.7	0.4	0	0.8	2.1	0.8	0.7	0.2	15.4	3.7	2.4	0	1.5	0	0.2	0.1	0.4	5.3	5.6	11.4	6.9	5.2	2.9	5.2	4	4.9	6.9	0	0.3	43.2	8.5	6.6	5.6	2	0	0	3.4	3.5	39.3	0.1	0	4.4	17.2	1.1	0	0	2.4	0.2	5.3	14	0	2.4	0.5	187.5	0	2.5	0.3	5.3	5.5	0.9	3.3	0	0.1	0.6	3.8	0	4.2	0	1.9	0	1.7	0	1.5	6.8	0	5.1	0	3.1	Horizontal cells
B3GAT2	GlcAT-S	ENSG00000112309	Beta-1,3-glucuronyltransferase 2	Q9NPZ5	6	70856679-70957038	Enzymes, Predicted membrane proteins		Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	9	brain: 27.2	Cell type enriched	Detected in many	9	Horizontal cells: 301.9	Group enriched	Detected in some	20	glioma: 4.7;testis cancer: 1.3	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	20	SCLC-21H: 22.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012059	Uncertain											HPA012059: AB_2061050	unprognostic (7.10e-3)	unprognostic (7.81e-2)	unprognostic (1.63e-1)	unprognostic (1.10e-3)	unprognostic (2.21e-1)	unprognostic (1.22e-2)	unprognostic (1.96e-2)	unprognostic (4.88e-2)	unprognostic (4.22e-2)	unprognostic (9.16e-4)	unprognostic (8.09e-2)	unprognostic (7.43e-3)	unprognostic (6.88e-7)	unprognostic (2.72e-2)	unprognostic (3.35e-2)	unprognostic (2.53e-2)	unprognostic (3.45e-3)	1.8	1.5	9.5	1.9	7.8	1.6	1.1	3.2	27.2	0.8	1.1	26.2	0	2.3	1.4	1.1	1.4	1.1	1.4	1.5	19.2	11.5	1	1.3	1.2	2	9.7	13.6	1.1	2.2	0.8	0.5	1.2	21	1.3	0.9	0.4	1.5	0.9	1.5	1.9	2.4	1.1	17.3	2	1.5	2.9	16.3	0	1.5	0	0.9	1.3	0.9	1.2	1	2	1.2	1.1	2.2	0.2	0.3	0	0.6	0.4	0	0	0.3	0.1	0	0	0	0	0.1	0.2	0.1	0	0.1	0.2	0.1	0	0	0.2	1.1	0.1	0.3	0.2	0	0.1	0.4	0	0	0	0	0.2	0	0.6	0.1	0.5	0	0.2	0	0.5	0.7	0.1	0.1	0.2	0.3	0.2	0	0.2	22.7	0.2	0	0.1	0	0.4	0.1	0	0.1	0.1	0.2	0.1	0.3	0.5	0	0.1	0.1	0.1	0.1	1.3	1.2	1.2	1	1	0.9	1	1.5	2.1	0.4	1.2	1.7	1.8	2	1.1	1.1	1	2.2	0.2	9.5	7.8	3.2	11.2	19.2	11.5	9.7	13.6	21	16.3	0	2.1	16.6	7.9	22.7	12.4	0.8	7.6	0	0	15.7	21.6	5.1	0	5	6.6	7.5	11	0	3.3	2.8	10.3	14.9	0	7.7	7	301.9	0	3.7	5.3	4	18.4	11.1	13.5	11.8	4.1	17.1	7.1	7	12.7	0.5	21.5	12.9	8.2	17.4	32.2	17.3	5.9	13.1	3.8	9.9	Horizontal cells
PCDHB3	PCDH-BETA3	ENSG00000113205	Protocadherin beta 3	Q9Y5E6	5	141100473-141103827	Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 17.3	Cell type enriched	Detected in some	4	Horizontal cells: 7.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 12.4;HAP1: 3.8;SH-SY5Y: 16.5;U-138 MG: 5.8	Low region specificity	Detected in all							HPA050296	Uncertain		Supported	Vesicles						Vesicles		HPA050296: AB_2681078	unprognostic (2.72e-2)	unprognostic (7.47e-4)	unprognostic (1.22e-1)	unprognostic (1.95e-4)	unprognostic (9.34e-3)	unprognostic (3.42e-2)	unprognostic (2.29e-2)	unprognostic (3.17e-1)	unprognostic (1.37e-1)	unprognostic (3.34e-1)	unprognostic (8.52e-3)	unprognostic (3.45e-2)	unprognostic (1.82e-2)	unprognostic (2.37e-3)	unprognostic (1.24e-1)	unprognostic (1.82e-2)	unprognostic (5.18e-4)	5.7	4.6	3.1	2.6	9.3	0.4	5.9	3.8	6.2	4.8	2.5	2.2	1.3	1.4	8	3	1.3	3.1	3.1	3.6	3.8	3	4.9	0.8	3.3	1	3	3.8	5.6	3.9	4.4	17.3	1.8	4	5.4	2.1	3.4	2.4	2.4	1.9	2	2.1	3.8	3	1.5	1.8	11.6	2	0	2.1	2.3	0.7	2.4	3.8	0	0	0	0	0	0	0	0	0	1.2	3.4	2.1	0.4	0.5	0.4	0	0	0	0	0	0	12.4	0.2	1.8	0	3.8	0.1	0	0.3	0	0	0.1	0	0	0	0.4	0.2	0	0	0	0.1	0	0	0	0.7	1.3	0	0.5	0	0.2	0	0	0.1	0.7	0	0	0	0.6	16.5	0	0.2	0	0.6	2.1	0.1	0	5.8	0.8	0.6	0.3	0.3	0	0	0.3	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	9.3	3.8	6.2	3.8	3	3	3.8	4	2	0	0	0	0.1	0	1.1	0.4	0	0	0	0	2	0	1.7	0.3	0.7	0.6	0	0	0.2	0	0.5	0.6	0	0	0	7.9	0	0.6	0	0	0.6	0	1.7	0	0	0.8	0.5	0	0.7	0	0.2	0	0.5	1.4	0.9	0.3	0	0	0	0.3	Horizontal cells
SLC12A7	DKFZP434F076, KCC4	ENSG00000113504	Solute carrier family 12 member 7	Q9Y666	5	1050376-1112035	Plasma proteins, Predicted membrane proteins, Transporters	Ion transport, Potassium transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Horizontal cells: 265.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		REH: 25.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA041652	Approved		Uncertain	Cytosol						Cytosol		HPA041652: AB_10793971	unprognostic (2.22e-2)	unprognostic (1.56e-1)	unprognostic (8.92e-2)	unprognostic (2.86e-1)	unprognostic (1.69e-2)	unprognostic (8.72e-2)	prognostic unfavorable (2.12e-6)	unprognostic (1.67e-1)	unprognostic (1.71e-3)	unprognostic (4.40e-2)	unprognostic (4.50e-2)	unprognostic (3.44e-2)	unprognostic (1.65e-3)	unprognostic (1.17e-3)	unprognostic (1.26e-1)	unprognostic (3.93e-2)	prognostic favorable (3.16e-5)	10.1	6.4	5.7	14.1	7.3	4.3	13	2.4	8.3	6.5	11.5	5.6	6.6	28	7.2	7.6	4.7	8.9	29.4	27.9	6.1	3.8	20.4	31.3	10	10.3	5.8	3.2	8.5	12.4	8.2	11.5	3.8	7.9	10.2	7	15.5	10.9	8.7	3.2	7.9	20.3	8.2	4.9	17.9	15.2	14.5	7.4	12.2	13.3	5.5	6.9	7.1	34.5	1.4	4.2	0.5	6.9	2.5	2.7	2.2	2.1	6	3.3	10.4	0.5	0.5	5.2	0.1	0.7	0.5	0	14.3	3.8	0	11.8	0.2	4.1	4.4	2.7	3.6	0	13	3.6	2.8	7.5	4.9	7.6	0	6.3	1.1	0.5	0	1.1	0.2	3.3	1.3	4	0.1	0	6.9	8.4	0	7.2	8.4	9.6	25.3	14.4	11.8	4	8.7	1.8	2.3	3.2	0	3.6	2.1	5.8	1.6	2.8	0	3.4	0	0	0.2	0	1.4	0	0.4	1.7	0.5	3.4	0	2.5	5.4	2.6	1.1	2.4	2.7	4.2	1.4	2.5	2.5	0	2.5	6.9	1.8	2.4	2.2	5.7	7.3	2.4	8.3	6.1	3.8	5.8	3.2	7.9	7.4	8.9	17.5	5.4	5.2	6.3	17.7	32.1	40.8	10.7	14.8	27.9	2	0.2	1.7	23	0.3	14.9	28.8	0	15.7	0.3	7.3	14.6	8.1	29.2	15.8	265.4	12.7	9.2	20.4	1.3	3.4	12.2	15.1	1.8	16.5	6.6	28	17.5	5.3	26.1	2.9	19.4	7.2	0.7	4.5	5.9	0.2	3.3	14.2	13.2	Horizontal cells
TNR		ENSG00000116147	Tenascin R	Q92752	1	175315194-175743770	Predicted intracellular proteins, Predicted secreted proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	19	brain: 56.4	Cell type enriched	Detected in some	168	Horizontal cells: 548.2	Cancer enriched	Detected in single	46	glioma: 9.9	Low region specificity	Detected in all			Cell type enhanced	Detected in single		NK-cell: 1.9	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		SH-SY5Y: 5.8;THP-1: 2.3;U-937: 4.3	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022343, HPA027134, HPA027150, HPA029859	Enhanced				Secreted in brain				230000			CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916	unprognostic (1.04e-1)	unprognostic (7.43e-2)	unprognostic (3.11e-2)	unprognostic (1.12e-3)	unprognostic (2.38e-1)	unprognostic (1.51e-2)	unprognostic (9.66e-2)	unprognostic (2.57e-2)	unprognostic (5.79e-2)	unprognostic (5.06e-2)	unprognostic (3.03e-3)	unprognostic (7.26e-4)	unprognostic (4.48e-4)	unprognostic (3.26e-3)	unprognostic (3.83e-1)	unprognostic (1.07e-1)	unprognostic (5.83e-2)	1.2	3	21.8	1.4	14.2	1.3	1.2	9.1	56.4	1.2	1.2	17.2	0	1.2	1.3	1.4	1.3	1.2	1.3	1.2	18.1	14.4	1.2	1.7	1.7	1.4	16.5	13.3	1.2	1.7	1.2	2	1.2	16.1	1.2	1.3	0.1	1.2	1.2	1.2	1.2	1.3	1.3	8.2	1.4	1.6	1.6	14.3	0	1.3	0	1.6	1.3	0.1	0.4	0.1	0.6	0	1.9	0.1	0	0	0.3	1.2	0.2	0.1	0.1	0.7	0.3	0.2	0.3	0.1	0.8	0.2	0.4	0.7	1.1	0.1	0.7	0	0.6	0.2	0.3	0	0.1	0.6	0.4	0	0.4	0.1	0.5	0.8	0.1	0.4	0.1	0.2	0.2	0.3	0.4	0	0.6	0.2	0.6	0	0.1	0.1	0.1	0	0.1	0	0.3	0.3	5.8	0.6	0.3	0.2	0.4	0.4	2.3	0.1	0.1	0.3	0.2	0	0	0	0.1	0.5	4.3	0.3	0.6	0	0.6	0	0	0	0.3	0.1	0	0	0.4	0.1	0.1	0.4	1.9	0	0.1	0	0	21.8	14.2	9.1	23.7	18.1	14.4	16.5	13.3	16.1	14.3	0	0	0	0	0	1.2	0.6	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	548.2	0	0	0	1	0	0	0	0	0	1.5	0	0	0	0.6	3.3	0	0	0	0	0	0.2	0	0	0	Horizontal cells
TRIM67	TNL	ENSG00000119283	Tripartite motif containing 67	Q6ZTA4	1	231162112-231221556	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	brain: 14.4	Cell type enriched	Detected in some	7	Horizontal cells: 65.2	Not detected	Not detected			Region enriched	Detected in many	7	cerebellum: 13.3	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 1.4;HMC-1: 1.6;HSkMC: 1.4;SCLC-21H: 7.2;SH-SY5Y: 1.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA034776	Uncertain											HPA034776: AB_10603997	unprognostic (1.56e-3)	unprognostic (1.54e-1)	unprognostic (5.20e-2)	unprognostic (5.39e-3)	unprognostic (2.95e-1)	unprognostic (3.82e-2)	unprognostic (6.02e-2)	unprognostic (4.63e-3)	unprognostic (1.84e-2)	unprognostic (1.74e-1)	unprognostic (4.93e-10)	unprognostic (1.45e-1)	unprognostic (2.88e-3)	unprognostic (4.25e-2)	unprognostic (1.53e-1)	unprognostic (2.30e-2)	unprognostic (5.10e-3)	0.3	0.7	1.3	0.2	1.3	0.1	0.1	13.3	14.4	0.2	0.2	0.1	0	0.5	0.1	0.1	0.1	0.1	0.2	0.3	1.2	1.9	0.2	0.1	0.1	0.2	1.5	0	0.2	0.2	0.1	1.9	0.4	1.9	0.1	0.2	1.7	0.2	0.1	0.1	0.4	0.3	0.2	0.9	0.2	0.2	0.5	0.2	0.1	0.2	0	0.1	0.2	0	0	0	0	0	0	0.6	0	0	0.8	0	0	1.4	0	0.2	0	0	0.1	0	0.5	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0	0.1	0	0	1.6	1.4	0	0	0	0	0	0.1	0	0.2	0	0.1	0	0	0.5	0.2	0.1	0.1	0	0.1	0	0	7.2	1.9	0	0.1	0.5	0	0	0	0	0.5	0	0	0	0.1	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0.6	0	0	0.1	0.1	0	0	0	0	0	0	1.3	1.3	13.3	1.9	1.2	1.9	1.5	0	1.9	0.2	0	0	0	0	0	9.5	0.9	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	65.2	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0	0	0.4	0	0	0.2	0	0	0	0	0	0	Horizontal cells
ONECUT2	OC-2	ENSG00000119547	One cut homeobox 2	O95948	18	57435685-57491297	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 18.6;gallbladder: 60.7;intestine: 18.0	Cell type enriched	Detected in many	6	Horizontal cells: 910.5	Group enriched	Detected in many	7	liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4	Region enhanced	Detected in many		basal ganglia: 18.6	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 18.7;HeLa: 11.9;RT4: 6.3;SCLC-21H: 9.8	Low region specificity	Detected in some			Group enriched	Detected in many	5	basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3	HPA057058	Enhanced		Supported	Nucleoplasm,Actin filaments						Nucleoplasm	Actin filaments	HPA057058: AB_2683323	unprognostic (3.02e-2)	unprognostic (5.36e-2)	unprognostic (9.06e-3)	unprognostic (3.79e-5)	unprognostic (1.13e-2)	unprognostic (4.48e-4)	unprognostic (2.10e-2)	unprognostic (1.81e-1)	unprognostic (3.75e-1)	unprognostic (4.56e-3)	unprognostic (8.66e-3)	unprognostic (1.16e-2)	unprognostic (5.34e-4)	unprognostic (3.83e-2)	unprognostic (2.58e-1)	unprognostic (1.13e-1)	unprognostic (3.21e-1)	0.3	0.4	0.3	0.3	18.6	0.2	0.3	3	3.7	0.2	16.5	0	0	15	0.3	0.3	0.3	0.2	60.7	0.2	0.5	0.9	0.3	12.8	0.3	0.3	0.5	0.9	0.3	4.3	3.2	5.1	0.2	1.1	0.3	0.3	0.7	0.3	0.3	0.3	0.3	18	0.3	0.3	0.3	0.5	0.6	6.6	0	0.3	0	0.2	0.3	0.2	0	0	0	0	0	0	0	0.5	0.9	1.1	3	0	0	1.2	0	0	0	0	0	0.2	0	0.8	0	1.4	0	3.3	0	0.1	18.7	3	0.7	11.9	2.7	0	0	0.5	0	0	0	0.2	0	0	2.2	3.6	0.6	0	0.4	1.7	0	0.1	1.5	0.7	0	1.1	0	1.6	6.3	9.8	1.6	0.1	0	0.2	0.1	0.4	0.7	0	1	1.3	0.2	0.2	0.3	2.7	0	0	0.8	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	18.6	3	3.7	0.5	0.9	0.5	0.9	1.1	6.6	0	0	0	0.2	0.1	3	2.6	155.4	0	0	7	13.7	0	0	69.5	2	0.6	0.3	0	7.6	0.1	0	0.3	0	44.2	0.8	910.5	8.5	9.2	0.6	2.8	0.3	0	0	0	0.7	2.9	24.1	3.1	0	0	4.9	0	0.7	1.4	1.7	0.1	0	0	0.4	0	Horizontal cells
PRLHR	GPR10, PrRPR	ENSG00000119973	Prolactin releasing hormone receptor	P49683	10	118589989-118595699	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 11.3;brain: 10.6;cervix, uterine: 8.3;pituitary gland: 11.8;smooth muscle: 8.1	Cell type enriched	Detected in single	15	Horizontal cells: 12.7	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in single	4	SH-SY5Y: 3.6	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA039361	Enhanced											HPA039361: AB_10673527					unprognostic (1.83e-1)						unprognostic (2.62e-3)	unprognostic (1.22e-1)		unprognostic (2.15e-2)	unprognostic (1.48e-1)	unprognostic (9.09e-2)		0.2	11.3	1.4	0.2	3	0.2	0.1	3.2	5.1	8.3	0.2	0.8	0	0.3	5.4	0.2	0.2	0.4	0.2	0.1	0.6	4	0.1	0.2	0.2	0.1	3.4	0.9	0.1	0.5	0.1	11.8	0.1	10.6	0.3	0.2	0.1	0.2	1.4	0.2	0.2	0.2	8.1	0.5	0.2	0.5	0.2	1	0	0.2	0	0.1	0.1	5.4	0.5	0.4	1.3	0.3	0.7	0.3	0	0	0.1	0.1	0	0	0	0.2	0	0	0	0	0	0	0.1	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0.8	0	0.1	0	0.1	0	0	0.1	3.6	0	0.1	0	0.1	0	0	0	0	0.4	0.1	0	0.1	0	0	0.3	0	0.1	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0	0.5	0.3	0.2	1.3	0.7	0.3	0.4	0	0	1.4	3	3.2	1.9	0.6	4	3.4	0.9	10.6	1	0	0	0	0.1	0	0.1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.7	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0.1	Horizontal cells
KCNJ2	IRK1, Kir2.1, LQT7	ENSG00000123700	Potassium voltage-gated channel subfamily J member 2	P63252	17	70168673-70180048	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel	Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 23.7;parathyroid gland: 34.8	Cell type enriched	Detected in many	8	Horizontal cells: 227.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in many	4	neutrophil: 20.8	Lineage enriched	Detected in many	4	granulocytes: 20.8	Cell line enhanced	Detected in some		hTERT-RPE1: 7.5;HUVEC TERT2: 5.2;REH: 6.0;RH-30: 24.5;U-138 MG: 9.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA029109	Approved											HPA029109: AB_10602913	unprognostic (1.32e-1)	unprognostic (1.24e-1)	unprognostic (1.18e-1)	unprognostic (6.22e-2)	unprognostic (3.50e-1)	unprognostic (6.36e-3)	unprognostic (1.22e-2)	unprognostic (3.14e-1)	unprognostic (1.09e-1)	unprognostic (1.62e-1)	unprognostic (3.64e-2)	unprognostic (1.03e-1)	unprognostic (1.74e-3)	unprognostic (6.15e-3)	unprognostic (9.60e-3)	unprognostic (4.89e-2)	unprognostic (5.49e-3)	3	1.5	6.2	6.3	17.9	2.5	6.6	1.3	12.8	1.8	5	23.7	5.1	1.6	1.5	1.2	4.7	8.4	2.2	11.4	6.4	4.4	1.7	1.9	3.9	4.4	22.4	8.5	1.4	1	34.8	1.6	9	11.7	2.6	4.3	3.1	2.7	2.9	10.3	6	2.1	1.6	14.9	10.4	2	0.9	18.2	0.5	1.9	6	2.2	2.6	3.3	0.1	0.7	20.8	4.7	0	0	0.4	0	0.7	1.5	0	1.6	0.4	0	0.5	3.7	0	0.1	0	0	0	0.3	0.4	1	0.4	0.1	0.2	0.1	0	0.2	0	0.5	0	4.7	0	0	1.7	0.1	2.3	0.2	7.5	5.2	0	0	0	1.6	0	0.5	0	0.1	0.6	0.1	6	24.5	0	0.6	0	0.3	0.7	0.4	0.1	0	3.1	0.2	0.4	0.1	9	0.1	0	2	0	0	0.1	1.9	0	1.2	1.8	2.5	3.6	0	4.7	0	0.1	0	0	0.7	0	0	0	20.8	0	4.6	0.1	0	0.4	6.2	17.9	1.3	12.8	6.4	4.4	22.4	8.5	11.7	18.2	0	2.7	0.8	5.2	7.2	6.6	14.2	0	5.3	1.2	1.8	0	0.5	0	0	0.2	8.7	2.6	0	0	0.1	0.8	1.7	0	0	5.7	227.2	10.3	3.7	28.3	0	1.4	5.2	3.3	1	2.8	5	0	11.2	1.1	0	4.6	0	2.2	0	0.4	2.9	1.1	0	6.6	0.1	Horizontal cells
GRIA3	GluA3, GLUR3, GLURC, MRX94	ENSG00000125675	Glutamate ionotropic receptor AMPA type subunit 3	P42263	X	123184153-123490915	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 40.8	Cell type enriched	Detected in some	22	Horizontal cells: 187.5	Cancer enriched	Detected in some	11	glioma: 10.2	Low region specificity	Detected in all			Cell type enriched	Detected in single	9	naive CD4 T-cell: 1.0	Lineage enriched	Detected in single	10	T-cells: 1.0	Cell line enhanced	Detected in some		BJ: 14.4;BJ hTERT+: 20.9;fHDF/TERT166: 27.5;U-2197: 9.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA058659, HPA073344	Enhanced				Intracellular and membrane							HPA058659: AB_2683791, HPA073344: 	unprognostic (2.14e-2)	unprognostic (6.00e-2)	unprognostic (2.02e-2)	unprognostic (2.94e-3)	unprognostic (5.09e-2)	unprognostic (4.29e-4)	unprognostic (2.42e-1)	unprognostic (6.74e-2)	unprognostic (1.44e-1)	unprognostic (2.36e-1)	unprognostic (1.65e-3)	unprognostic (1.31e-1)	unprognostic (3.78e-3)	unprognostic (8.05e-3)	unprognostic (6.40e-2)	unprognostic (1.57e-1)	unprognostic (2.03e-1)	1.5	10.7	31.4	1	27.4	0.7	2.3	3.5	40.8	9.1	1.3	3.7	0.1	0.9	3	4.9	1.1	2	1.9	2.7	26.1	8.1	3.4	9.3	1	1.1	10.2	21.2	5.6	2.6	0.6	0.6	1.1	4.9	2.1	1.5	0.7	0.9	3	0.9	1.2	1	2.9	8.4	0.7	3	1.4	7.8	0	0.8	0	1.5	1.3	1.8	0	0	0.1	0	0	1	0	0	0	0	0	1.3	0.2	0	14.4	20.9	0.2	0.5	0	0	0	0	27.5	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0.1	4.9	0	0.1	0	0	0	0	0	0	0	0	0	0.8	0	0.4	0	0	0	0	0	0.3	0.9	0	0	0	0.5	0	0	0	4.1	0	9.2	0.1	0	0	0	4.1	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	1	0	0	0	0	0	0	0	31.4	27.4	3.5	27.5	26.1	8.1	10.2	21.2	4.9	7.8	0	0	0	0	0.2	4.6	1.5	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.2	0	3.1	0.5	0	4.7	0.1	187.5	0	0.6	0	0	8.6	0	1.7	0	0	1.5	0.5	0	3.9	6	3.1	0	0.5	0	0	0.9	0.1	0	0	0	Horizontal cells
LAMP5	BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46	ENSG00000125869	Lysosomal associated membrane protein family member 5	Q9UJQ1	20	9514358-9530524	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 42.1;brain: 105.2	Cell type enriched	Detected in some	7	Horizontal cells: 57.2	Low cancer specificity	Detected in all			Region enriched	Detected in all	5	basal ganglia: 105.2	Cell type enriched	Detected in some	15	plasmacytoid DC: 42.1	Lineage enriched	Detected in many	30	dendritic cells: 42.1	Cell line enhanced	Detected in some		Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA004802, HPA070765	Enhanced		Uncertain	Mitotic spindle,Centriolar satellite,Cytosol						Cytosol	Mitotic spindle, Centriolar satellite	HPA004802: AB_10603682, HPA070765: AB_2686309	unprognostic (2.78e-2)	unprognostic (3.90e-3)	unprognostic (5.73e-4)	unprognostic (5.47e-2)	unprognostic (7.89e-2)	unprognostic (2.67e-1)	unprognostic (3.80e-3)	unprognostic (1.45e-1)	unprognostic (1.54e-2)	unprognostic (1.91e-1)	unprognostic (1.94e-1)	unprognostic (1.95e-1)	prognostic unfavorable (6.46e-6)	unprognostic (5.12e-3)	unprognostic (3.74e-2)	unprognostic (1.08e-2)	unprognostic (4.49e-3)	0.5	4.1	21.6	1.5	105.2	2	1	2.3	28.6	9.1	1.3	0.6	1.8	1.3	4.6	6	0.6	9.7	2.9	0.6	18.7	4.1	0.9	0.5	1.1	4.8	4.5	7.7	21.2	1.3	0.3	2	0.4	23.2	2.3	1.4	2.6	1.4	3.6	0.3	0.5	1.4	3.8	6.7	1.4	1.6	1.1	4.8	0	1.1	0	4.7	1.2	0.6	1.4	42.1	0.9	0.5	0	0	0.7	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.8	0.1	0	0	0	0	0	0	0	0	95	0	0	0	0	0.4	0	0	0.4	0	0	0	0	0	17.4	0	0	0	0.1	0	33.1	0	0	0	0	0	0	0	0	0	4.1	0	0.9	0.5	0	0	0.1	0	1.4	0	0	2.8	0.1	0	0	0.1	0	0	42.1	0	0.7	21.6	105.2	2.3	19.1	18.7	4.1	4.5	7.7	23.2	4.8	0	1.4	2.2	0	0.1	7.5	0.2	0	0	0	0	7.9	0	0	0.6	5.8	0.1	0	0	0	0	0.6	0.8	0	0	1.1	57.2	0	0	1.2	5.6	0.6	0.2	3.3	8.2	0	4	0.2	0	0	0	4.9	0	1.4	0.2	0.1	0	0	0	0	0	Horizontal cells
C1QL1	C1QRF, C1QTNF14, CRF	ENSG00000131094	Complement C1q like 1	O75973	17	44959693-44968071	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 42.5	Cell type enriched	Detected in some	51	Horizontal cells: 635.6	Cancer enriched	Detected in all	7	glioma: 116.0	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		SCLC-21H: 18.2;SH-SY5Y: 13.0;U-2 OS: 45.6;U-251 MG: 13.7;U-87 MG: 14.7	Low region specificity	Detected in many			Low region specificity	Detected in all								Secreted in brain								unprognostic (6.37e-2)	unprognostic (1.13e-1)	unprognostic (2.29e-1)	unprognostic (3.63e-3)	unprognostic (3.15e-2)	unprognostic (2.05e-2)	unprognostic (7.65e-2)	unprognostic (3.40e-3)	unprognostic (2.34e-1)	unprognostic (6.64e-3)	unprognostic (1.49e-2)	unprognostic (1.44e-1)	prognostic unfavorable (1.31e-8)	unprognostic (2.67e-2)	unprognostic (1.05e-1)	unprognostic (1.61e-2)	unprognostic (3.04e-1)	2.5	2.3	20.2	2	9.7	1.3	1.5	4.9	42.5	1.6	2.9	12.7	0	5.2	5	2	2.5	1.8	1.8	1.8	14.4	16.3	6.4	1.4	1.3	1.3	13.3	10.4	1.3	4.3	1.2	0.7	1.3	35.2	11.6	1.8	10.3	1.4	1.4	1.2	1.6	3.9	2.5	12.8	1.3	4.4	1.6	8.5	0	1.4	0	1.2	2.3	0.4	0	0	0	0	0	0	0	2.2	2.6	0.6	9.2	0.2	0	0.2	0.3	0.4	0.3	0.8	0.3	0.3	0.1	1.5	0.2	2.8	0.3	1.5	0.1	0.1	5.9	3.9	0	4.2	0	1.1	0	1.1	0.2	0	0.4	0.1	3.2	0	1.6	0	0.1	0.2	0.5	1.9	0	1.5	0.2	5.6	3.2	0.1	0.1	0	0.2	18.2	13	7.8	0.7	0.6	0.5	2.1	0.1	0	0.7	45.6	0.5	13.7	0.5	0	0	14.7	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.2	9.7	4.9	13.9	14.4	16.3	13.3	10.4	35.2	8.5	0	0	0	0.2	0.2	6.4	0.8	5.1	0	0	0	9.8	0	0	0	0	0	0	0	0	0.1	0.7	0.2	0	0	0	635.6	5.1	0	0	0	0.3	0	0	0	0	12.4	0.1	0	0	0	10.6	0	0.3	0.2	1	0	0	0	0	0	Horizontal cells
DTX1	hDx-1, RNF140	ENSG00000135144	Deltex E3 ubiquitin ligase 1	Q86Y01	12	113056709-113098028	Enzymes, Predicted intracellular proteins	Notch signaling pathway	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 9.7;lymphoid tissue: 13.3	Cell type enriched	Detected in many	15	Horizontal cells: 162.1	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in some		naive B-cell: 2.3	Low lineage specificity	Detected in many			Group enriched	Detected in some	12	Daudi: 40.9;REH: 16.8;U-698: 41.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA051249, HPA055275	Approved		Supported	Nucleoplasm,Nuclear bodies,Cytosol						Nucleoplasm, Cytosol	Nuclear bodies	HPA051249: , HPA055275: AB_2682769	unprognostic (2.13e-3)	unprognostic (3.20e-3)	unprognostic (4.24e-4)	unprognostic (2.01e-1)	unprognostic (7.48e-3)	unprognostic (1.59e-3)	unprognostic (2.49e-3)	unprognostic (1.81e-1)	unprognostic (9.55e-2)	unprognostic (6.87e-2)	unprognostic (2.19e-1)	unprognostic (1.58e-1)	prognostic unfavorable (3.02e-5)	unprognostic (2.41e-2)	unprognostic (4.70e-1)	unprognostic (1.63e-1)	unprognostic (4.78e-3)	9.7	2.3	6.1	8.9	7	3.2	3.9	7.3	8.3	0.8	0.7	1.1	0.5	1.6	2	0.5	1.2	1.7	1	2.7	5.4	5.9	1.7	6.4	0.5	13.3	3.7	4.2	0.5	2	0	2.2	0.9	4.6	0.8	0.2	1.4	3.2	0.5	0.5	0.5	2.2	0.5	1.1	9.8	1	4.9	0.5	0.5	1.3	0.5	8.1	0.5	0.5	2.3	0	0	0	1	0.6	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	40.9	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0.1	0	0	0	0	0	0	0.9	0.2	0	0	0.1	1.7	0	0.8	0	0	16.8	0	1	0	0	1	2.7	0.1	0.1	1	0	0	0.1	0.4	0	1.6	0	0	0.2	0	41.6	0	0	0	0	0	0	0	0	0.4	0.7	0.5	0	0	2.3	0.6	0	0	1	0	0	0	0.2	6.1	7	7.3	7.1	5.4	5.9	3.7	4.2	4.6	0.5	0	0	2.9	0	0.9	1.5	0.7	0	0	0	1.8	7.9	0	6.6	1.6	0.6	0.7	0	0	0	0	0.8	0.1	6.9	10.5	0.6	162.1	0	0	0	1.1	7.2	0	3.3	0	0	10.3	0.2	0	7.1	0	2.1	0	0.9	0.7	1.2	0.4	0	0	0	0	Horizontal cells
GJA10	CX62	ENSG00000135355	Gap junction protein alpha 10	Q969M2	6	89894469-89921760	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	12	testis: 2.3	Cell type enriched	Detected in single	148	Horizontal cells: 17.5	Cancer enriched	Detected in single	7	testis cancer: 1.9					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HAP1: 2.8;NTERA-2: 1.6	Not detected	Not detected			Low region specificity	Detected in single			HPA021145	Uncertain											HPA021145: AB_2670600															unprognostic (1.09e-1)			0	0.1	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0.1	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	2.3			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	Horizontal cells
SLC9A5	NHE5	ENSG00000135740	Solute carrier family 9 member A5	Q14940	16	67237683-67272190	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Antiport, Ion transport, Sodium transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 13.5;lymphoid tissue: 14.5	Cell type enriched	Detected in some	5	Horizontal cells: 15.9	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-138 MG: 8.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041004, HPA041329	Uncertain		Uncertain	Plasma membrane,Cytosol						Cytosol	Plasma membrane	HPA041004: AB_10794433, HPA041329: AB_10794373	unprognostic (8.90e-2)	unprognostic (9.70e-2)	unprognostic (3.39e-3)	unprognostic (1.37e-1)	unprognostic (1.44e-1)	unprognostic (1.43e-1)	unprognostic (2.24e-2)	unprognostic (5.17e-2)	unprognostic (1.50e-1)	unprognostic (1.12e-1)	unprognostic (2.50e-3)	unprognostic (4.84e-2)	unprognostic (9.85e-11)	unprognostic (9.21e-2)	unprognostic (1.95e-1)	unprognostic (8.12e-3)	unprognostic (9.07e-2)	1.7	1.7	2.9	1.1	8.8	0.5	1.1	13.5	8.6	0.9	1.4	0.5	3.6	1.3	1.1	3.2	0.6	0.6	1.9	2.3	2.9	3.6	1.1	0.6	2.9	2.1	2.1	2.3	1.4	1.5	0.5	0.6	1.7	4.3	1	1.1	0.5	1	2.5	1.7	4.2	0.9	0.6	2.7	14.5	0.8	3.3	1.2	0	1	0	1.3	1.6	0.4	1.5	0.8	1	0.5	0.6	0.9	0.1	0.5	4.1	3.7	1.2	6.8	4.7	0.4	1.3	5.8	3.4	3.1	0.2	2.9	0	0.8	1.6	1.7	0.2	1	0.7	1.3	1.2	1.2	3.2	0.3	0.9	0.8	1.4	6.7	5.3	1.4	1.9	0.4	6.3	0.7	1.2	0.7	1.9	2.2	2.3	0.1	0.3	2.5	0.2	0.4	0	0.8	0.9	0.6	0.7	2.1	0.9	3.5	0.2	1.8	0.9	1.4	0.3	1	8.8	1.4	1.6	0.6	3.6	0.9	1.8	6.3	0.7	2.2	0	0.4	0	0	0	0.6	1.5	0.4	0.9	0.1	0	0.4	0.4	1	0.6	0.5	0.8	0	0.1	2.9	8.8	13.5	8.6	2.9	3.6	2.1	2.3	4.3	1.2	3	3.2	0	0.1	0.6	1.9	1.2	2.5	0	0	0	0	0.2	0	0.3	0.6	0.7	0	0	0.2	0.1	0.6	0.4	0	0	0.1	15.9	1.2	2.5	0	0	0.3	0	0	1	0	0.3	0.4	0	2.1	0	0.6	0	0.7	1.7	1.1	0.6	0	0	0.2	0.1	Horizontal cells
RTN1	NSP	ENSG00000139970	Reticulon 1	Q16799	14	59595976-59870966	Plasma proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	8	brain: 144.6	Cell type enriched	Detected in many	4	Horizontal cells: 227.2	Cancer enhanced	Detected in many		glioma: 19.0	Low region specificity	Detected in all			Group enriched	Detected in some	6	classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9	Group enriched	Detected in many	15	dendritic cells: 7.9;monocytes: 4.6	Group enriched	Detected in some	4	HEL: 23.2;SCLC-21H: 28.7;SH-SY5Y: 46.0	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB002745, HPA040945, HPA044249	Enhanced		Supported	Nuclear bodies,Endoplasmic reticulum					140000	Endoplasmic reticulum	Nuclear bodies	CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874	unprognostic (9.40e-3)	unprognostic (1.43e-3)	unprognostic (3.20e-2)	unprognostic (2.61e-1)	unprognostic (4.24e-2)	unprognostic (3.04e-3)	unprognostic (8.67e-2)	unprognostic (1.23e-2)	unprognostic (2.49e-1)	unprognostic (2.79e-1)	prognostic favorable (3.69e-4)	unprognostic (5.79e-2)	unprognostic (2.23e-1)	unprognostic (4.00e-2)	unprognostic (1.75e-1)	unprognostic (6.71e-2)	unprognostic (1.62e-2)	6.3	8.3	27.4	6.1	46.3	1.6	3	98.5	144.6	2.6	2.9	11	0	2.7	2.1	1.6	2.3	8.6	4.4	1.9	32.3	50.7	2.3	1.9	4.8	2.7	21.3	45.9	1.7	3.6	19.2	10.3	2.7	35.1	5	3	1.2	2.3	2.6	1.6	2.3	3.4	2.7	12.1	10.6	3.6	2.6	10.5	0	2.7	0	2.3	2.5	0.9	0	7.9	0.4	4.6	0	0	1	0	0	0.3	0.4	1.2	0	0	0	0	0.6	0	0	0	0	0	0	0.2	0	0.3	0	0.1	0	0.8	23.2	0	0	1.3	0	0.1	0	0	0	0.8	0	0.2	0.1	0	0.1	0.2	0.1	0	0	1.9	0	0	0	0.2	0	0	0	28.7	46	5.7	0	0	0	0	0	0	3.9	1.1	0	2.1	0	0	0	7.7	1.6	0.2	0	4.5	0	0	4.6	0	0	0	0	7.9	0	0	0	0.4	0	0.9	0	0	1	27.4	46.3	98.5	94.7	32.3	50.7	21.3	45.9	35.1	10.5	0	0.6	0	0.4	4.2	26.8	0.8	2.5	1.4	1.2	0	23.6	0.8	0	0	13.2	0.5	0.2	0	0	0.7	2.1	6.2	0	0.4	15.8	227.2	51.9	0	15.9	14.4	2.6	24.4	10.1	1.8	0	13.1	2.2	0	1.1	0.3	29.4	0	2.1	2.1	2.5	5.6	2.1	0	0.2	0.3	Horizontal cells
CACNG8		ENSG00000142408	Calcium voltage-gated channel auxiliary subunit gamma 8	Q8WXS5	19	53963040-53990215	Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	blood: 7.9;brain: 22.8	Cell type enriched	Detected in many	7	Horizontal cells: 47.7	Cancer enriched	Detected in single	5	glioma: 1.6	Group enriched	Detected in many	5	amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4	Cell type enriched	Detected in some	7	basophil: 7.9	Lineage enriched	Detected in single	17	granulocytes: 7.9	Group enriched	Detected in some	5	AF22: 6.4;HMC-1: 21.3;hTERT-RPE1: 7.6;TIME: 13.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA041351	Enhanced											HPA041351: AB_10796666	unprognostic (7.01e-2)	unprognostic (6.27e-2)	unprognostic (3.06e-1)	unprognostic (5.29e-4)	unprognostic (9.66e-2)	unprognostic (2.17e-2)	unprognostic (1.38e-1)	unprognostic (9.40e-3)	unprognostic (6.13e-2)	unprognostic (2.03e-1)	unprognostic (7.63e-2)	unprognostic (2.58e-1)	unprognostic (2.82e-8)	unprognostic (1.10e-1)	unprognostic (1.35e-1)	unprognostic (1.63e-1)	unprognostic (1.17e-1)	0.4	0.4	9.4	0.4	9.1	0.6	0.4	0.7	22.8	0.3	0.3	2.1	0	0.4	0.5	0.4	0.3	0.4	0.4	0.3	20.3	5.4	0.3	0.3	0.4	0.4	2.3	2	0.4	0.3	0.5	0	0.3	1.5	0.4	0.4	0	0.4	0.3	0.9	0.7	0.4	0.4	0.9	0.4	0.6	1.5	0	0	0.4	0	0.3	0.3	0	0.4	0.3	7.9	0.2	0.3	0.3	0.1	0	2.1	6.4	0.2	0	0.1	0.1	0.1	0.3	0	0.2	0.4	0.3	0	0.2	0	0.3	0.2	0.1	0.1	0	0	0.9	2.4	0.5	0	1	0	21.3	0.3	0	0	0.2	7.6	2.1	0.1	0.1	0.2	0	0.1	0	0	1.3	0.2	2.6	0	0	0	0	0.1	0.1	1.4	0.1	0.1	0	0.2	0.2	0	13	0.1	1.2	0	0	0.1	0	0	2.1	0	0.1	7.9	0.2	1.1	0.2	0.1	0.2	0.2	0.2	0.2	0	0.4	0.3	0.2	0.5	0.3	0.1	0.3	0.1	0.1	9.4	9.1	0.7	13.6	20.3	5.4	2.3	2	1.5	0	0	0	0	1	1.4	0.9	2.8	0	4	1.2	1.8	0	0	0	1.4	0.4	1.9	0	0	0	0	0.5	1.3	0	0	0.1	47.7	0	3.1	1.5	1.1	0	0	0	0	0.4	1	0.1	0	0.4	0	1.5	0	0.8	5	6.4	1	0.1	0	0.5	1	Horizontal cells
BARHL2		ENSG00000143032	BarH like homeobox 2	Q9NY43	1	90711539-90717237	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	4	brain: 29.3	Cell type enriched	Detected in some	5	Horizontal cells: 22.3	Not detected	Not detected			Region enriched	Detected in single	42	cerebellum: 29.3	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 2.5;HEK 293: 8.9;HEL: 1.3;HMC-1: 2.5;JURKAT: 1.5	Region enriched	Detected in some	5	cerebellum: 14.5	Region enriched	Detected in many	20	cerebellum: 48.3																		unprognostic (1.83e-1)				unprognostic (1.73e-1)	unprognostic (6.80e-2)				unprognostic (3.10e-1)	unprognostic (1.60e-1)			0	0	0	0	0	0	0	29.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0.4	0	0	0	0	0	0	0.2	0	0	7.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	8.9	1.3	0	0	0	0	2.5	0	0	0	0	0	0	1.5	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.8	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29.3	0	0	0.7	0	0	0	0	0	0	0	0	0	0.6	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	22.3	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.6	0	0	4.1	3.6	0	0	0	0	0	Horizontal cells
GPR161	RE2	ENSG00000143147	G protein-coupled receptor 161	Q8N6U8	1	168079543-168137667	G-protein coupled receptors, Predicted membrane proteins, Transporters		Developmental protein, G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		endometrium 1: 27.1;smooth muscle: 21.0	Cell type enriched	Detected in many	8	Horizontal cells: 149.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		CACO-2: 24.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA015576, HPA072047	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	HPA015576: AB_1849283, HPA072047: AB_2686484	unprognostic (1.45e-1)	unprognostic (3.78e-2)	unprognostic (2.68e-2)	unprognostic (1.58e-3)	unprognostic (1.87e-1)	unprognostic (6.84e-2)	unprognostic (3.24e-3)	unprognostic (1.48e-1)	unprognostic (1.19e-1)	unprognostic (5.04e-2)	unprognostic (5.45e-2)	unprognostic (1.31e-2)	unprognostic (5.57e-6)	unprognostic (3.93e-2)	unprognostic (1.84e-2)	unprognostic (1.03e-2)	unprognostic (6.34e-2)	2.4	0.9	2.1	3.6	1.7	0	1.9	1.2	4	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3	1.2	7.6	11	4.9	1.3	1.3	3	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21	3	1.2	2.2	3	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.5	9.9	3.7	6.6	0	5.9	6.5	5.1	5.4	24	1	0	3.3	8.9	9.6	18.4	3.7	5.8	3	2.3	4.8	2.2	3	0.1	1.6	0.6	1.5	2.3	3.8	4.4	7.1	11.9	10.2	1.9	2	0.1	7.7	0.5	0.7	0.1	6.3	10.3	6	1.8	6.7	0	2.7	1.7	3.1	13.7	6.5	0.2	17.8	6.1	3.4	0.7	13.7	10.5	5.5	14.1	6.7	0	0	0	2.8	0	2.7	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0	0.2	2.1	1.7	1.2	4	2.8	1.5	3	1.2	3	0.8	3	0.6	0	5	1.9	1.7	2	0	1.4	1.2	0	0	0.4	0	3.6	0.4	6.3	0	0	7.2	0.2	6.3	4.6	0	0	0.7	149.4	0	4.3	1.8	0.6	6.9	1.3	1.7	1.8	1.7	2.7	2.9	0	15.9	0	1.5	19.4	12.2	0	0.7	1.3	0.3	0	2.3	2.3	Horizontal cells
DRD2		ENSG00000149295	Dopamine receptor D2	P14416	11	113409615-113475691	FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in many	8	adrenal gland: 17.3;brain: 52.0;pituitary gland: 51.6	Cell type enriched	Detected in some	12	Horizontal cells: 57.2	Low cancer specificity	Detected in some			Region enriched	Detected in many	5	basal ganglia: 52.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	9	SCLC-21H: 45.2	Region enriched	Detected in many	10	basal ganglia: 183.8	Group enriched	Detected in many	8	basal ganglia: 126.7;midbrain: 41.7	HPA015139, HPA015691	Supported	Supported										HPA015139: , HPA015691: AB_1847834	unprognostic (8.49e-2)	unprognostic (2.11e-1)	unprognostic (1.69e-1)	unprognostic (1.29e-4)	unprognostic (2.32e-2)	unprognostic (1.15e-1)		unprognostic (1.97e-2)	unprognostic (5.89e-2)	unprognostic (4.40e-2)	unprognostic (8.33e-4)	unprognostic (1.10e-1)	unprognostic (6.65e-3)	unprognostic (2.29e-1)	unprognostic (1.71e-1)	unprognostic (4.82e-2)	unprognostic (8.49e-3)	0.6	17.3	0.9	0.5	52	0.2	2.1	0.2	3.3	1.3	0.6	1.5	0	0.3	2.3	0.4	0.9	2.1	0.6	0.5	0.3	4.1	0.3	0.2	0.6	0.2	9.9	0.2	0.3	0.4	0.3	51.6	0.2	2.4	1.5	0.9	3.9	5.1	1.7	1.7	0.3	0.5	3.2	0.2	0.2	0.5	1.6	9.5	0	0.2	0	0.3	0.3	0.3	0	0	0.2	0	0	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0	3.7	0.1	0	0	0	3.1	0	0	0	0	2.3	0	0	0	0	0	0	5.1	0	0.8	0	0.6	0	0	0	0	0	1.5	0.2	0	0	0.5	0	0	0	4.8	0	0	0	45.2	5.1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.6	0	0.9	52	0.2	3.3	0.3	4.1	9.9	0.2	2.4	9.5	0	0	0	0	0	4.9	1.1	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	57.2	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	Horizontal cells
GPR158	KIAA1136	ENSG00000151025	G protein-coupled receptor 158	Q5T848	10	25175062-25602226	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 28.4;seminal vesicle: 11.2	Cell type enriched	Detected in some	5	Horizontal cells: 136.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HEL: 21.2;T-47d: 5.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA013185	Uncertain											HPA013185: AB_2113957	unprognostic (4.43e-2)	unprognostic (3.14e-2)	unprognostic (7.42e-2)	unprognostic (2.66e-5)	unprognostic (5.67e-2)	unprognostic (9.37e-2)	unprognostic (4.73e-2)	unprognostic (1.85e-1)	unprognostic (1.22e-1)	unprognostic (4.37e-2)	unprognostic (8.09e-3)	unprognostic (1.72e-1)	unprognostic (2.60e-6)	unprognostic (8.36e-2)	unprognostic (1.78e-1)	unprognostic (1.21e-3)	unprognostic (3.90e-1)	0.9	2.4	3.6	1	16.2	0.8	0.8	28.4	25.2	0.8	1.1	1.6	6.1	0.9	0.8	1	0.8	0.8	0.8	0.8	1.9	2.8	0.8	0.9	0.9	0.8	2.4	4.8	0.8	0.9	1.5	8.9	1.5	14.9	1.2	1.1	1.4	0.8	11.2	0.8	0.8	1.2	0.8	4	0.9	1.1	1.9	2.9	0	1	0	0.8	0.8	0.4	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	1.7	0.1	0	0.2	0	0	0	0	2.6	0	21.2	0	0	0	0	1.2	0	0	0	0	0	0	0	0.7	0	0.2	0.4	0	0	0.1	0	0.5	0	0.4	0.2	0	0	1.2	0	0.5	1.1	1.9	0	5.8	0	0	0	0.5	0.3	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	16.2	28.4	11.6	1.9	2.8	2.4	4.8	14.9	2.9	0	0	0	0	0	2.1	0.4	0	0	0	0	0	0.4	0	0	15.5	0	0	0	0	0.6	0	0.5	0	0	0.1	136.7	0	0	0	8.8	0	0	0	0	0	27.6	0	0	0	0	3.4	0	0	1.8	0.7	0	0.2	0	0	0	Horizontal cells
CACNA1C	CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS	ENSG00000151067	Calcium voltage-gated channel subunit alpha1 C	Q13936	12	1970786-2697950	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Calcium transport, Host-virus interaction, Ion transport, Transport	Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel	Autism, Autism spectrum disorder, Brugada syndrome, Disease mutation, FDA approved drug targets, Long QT syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 32.5	Cell type enriched	Detected in many	4	Horizontal cells: 284.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		NK-cell: 4.2	Group enriched	Detected in many	19	NK-cells: 4.2;T-cells: 1.2	Cell line enriched	Detected in some	17	HDLM-2: 47.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039796, CAB079031	Enhanced	Approved										CAB079031: , HPA039796: AB_10673019	unprognostic (1.76e-1)	unprognostic (1.19e-1)	unprognostic (6.29e-2)	unprognostic (9.35e-2)	unprognostic (3.71e-2)	unprognostic (1.60e-2)	unprognostic (4.68e-2)	unprognostic (7.99e-2)	unprognostic (3.07e-2)	unprognostic (1.03e-5)	unprognostic (1.93e-2)	unprognostic (1.01e-1)	unprognostic (4.02e-7)	unprognostic (8.85e-2)	unprognostic (3.60e-2)	unprognostic (6.90e-2)	unprognostic (3.39e-2)	3.8	2.5	8.6	6	7.7	1.4	2.4	7.1	11.7	11.2	26.5	1.3	7.4	2.4	29.7	4.5	5.2	4.3	7.1	32.5	5.5	4	2.7	1.4	4.7	2	2.4	6.6	2.7	3.2	1.5	8.1	5.1	3.9	7.9	3.8	6.5	2.4	8.1	2.3	1.7	5.2	28.8	1.9	3.5	7.2	11.3	1.7	0	2	1.1	1.7	12.6	5.4	0	0.1	0	0.1	4.2	1.2	0.2	0	0	0	0	1.6	1.1	0.1	1.7	2	1.1	0.8	0	0	0	0	1.1	0	0	0	0	0.5	47.6	0.4	0.6	0	0	1.2	0	0	2.7	0	0.6	0	0.1	0	0.2	0	0.1	0	0	0.1	0	0.4	0	0	0.1	0	0	0	0	0.6	0.2	0	0	0	0.6	0	0	0	2.7	0.3	2.6	0	0	0	0	2.2	0.1	0.6	0	0	0	0.6	0	1.2	0	0.5	0.7	0	0	0.9	0.7	0	4.2	0.1	0.1	0.4	0.2	8.6	7.7	7.1	11.7	5.5	4	2.4	6.6	3.9	1.7	0	0	0	1.2	0.6	15.3	42.8	0	0	0	0	2	0.1	0	0	27.5	2.9	0	0	0	0.2	2.5	1.4	0	0	0.2	284.4	35.2	2.5	0	64.7	0.9	0	0	0	0.6	6.1	0.3	0.2	3.9	0	1.2	12.9	17.5	2.6	5.8	0.1	0.1	0	0.4	2.4	Horizontal cells
GRIA4	GluA4, GLUR4, GLURD	ENSG00000152578	Glutamate ionotropic receptor AMPA type subunit 4	P48058	11	105609994-105982092	Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 55.4	Cell type enriched	Detected in some	22	Horizontal cells: 444.9	Group enriched	Detected in some	18	glioma: 5.9;renal cancer: 1.2	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 15.8;NTERA-2: 5.2;RPMI-8226: 3.0;SCLC-21H: 5.8	Low region specificity	Detected in all			Low region specificity	Detected in all								Intracellular and membrane								unprognostic (1.45e-1)	unprognostic (2.63e-1)	unprognostic (4.09e-4)	unprognostic (4.45e-3)	unprognostic (1.92e-3)	unprognostic (4.14e-4)	unprognostic (1.40e-2)	unprognostic (3.73e-4)	unprognostic (1.62e-1)	unprognostic (3.89e-1)	unprognostic (2.04e-1)	unprognostic (1.53e-1)	unprognostic (1.70e-1)	unprognostic (2.48e-1)	unprognostic (1.38e-1)	unprognostic (3.35e-2)	unprognostic (1.28e-1)	1.1	7.4	11.4	1.5	13.1	0.9	4.5	55.4	52.9	2.6	1.8	8.1	0	0.9	1.5	2.9	1	2.2	1.2	0.9	9.3	16	1.4	0.9	1	1.6	12.1	17.4	1.3	1.6	0.9	2.2	1.3	24.8	1.2	2	2.8	4.1	1.5	1	1.5	4.5	1	11.5	0.9	6.6	1.1	6.9	0	1	0	1.3	1	0.2	0.2	0	0	0	0	0.2	0	0	0	15.8	0	0	0	0	0	0.6	0	0	0	0	0	0.1	0	0.2	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	5.2	0	0.2	0	0	3	0	0	5.8	1.9	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0.2	0.2	0	0	0	0	0	0	0	11.4	13.1	55.4	23.3	9.3	16	12.1	17.4	24.8	6.9	0	0	0	0	0.1	18.9	1.1	0	0	0	0	2	0	0	0.3	0.4	0	0	0	0	0	0.2	0	0	0	0.8	444.9	0	0	0	0	0.6	0	0	0	0	20.1	0	0	0	0.5	7.7	0	0	0	0	0.1	0.2	0	0	0	Horizontal cells
NRSN1	p24, VMP	ENSG00000152954	Neurensin 1	Q8IZ57	6	24126122-24154900	Predicted intracellular proteins, Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	5	brain: 67.2	Cell type enriched	Detected in some	5	Horizontal cells: 114.4	Cancer enriched	Detected in single	17	glioma: 3.1	Low region specificity	Detected in all			Cell type enhanced	Detected in some		basophil: 1.8	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		SCLC-21H: 14.6;SH-SY5Y: 11.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA019681, HPA061006	Uncertain		Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA019681: , HPA061006: AB_2684413	unprognostic (1.22e-1)		unprognostic (4.26e-2)	unprognostic (8.00e-3)	unprognostic (8.01e-3)					unprognostic (1.70e-1)	unprognostic (4.53e-3)	unprognostic (7.29e-2)	unprognostic (1.36e-3)	unprognostic (2.40e-3)	unprognostic (1.45e-1)	unprognostic (1.57e-1)		1.3	6.9	21.5	1.7	27.7	1.7	1.3	5.3	67.2	1.3	1.7	2.1	0	1.7	1.5	1.4	1.4	1.3	1.5	1.4	15.3	25	1.5	1.4	1.4	1.5	12.4	25.4	1.3	2.6	1.4	12.9	1.3	27.4	1.4	1.7	0.3	1.5	1.3	3.3	1.5	1.6	1.6	6.7	1.5	1.9	1.6	5	0	1.4	0	1.3	1.3	0.1	0.5	0.2	1.8	0.2	0.1	0.3	0	0.7	0	0.3	0.7	0	0	0	1.4	0	0	0	0.2	0.7	0.1	1.7	0	0	0.3	0.1	0	0.1	1.7	0.6	0	0.1	0.2	0	0.1	0.2	0.1	0	0.1	0	0.1	0	0.3	2	1.3	0.1	0.2	0.3	0.9	0.7	0.2	2.5	0.5	0.2	0.5	0	0	14.6	11.7	0	0.1	0.9	0.2	1.7	3.5	0.2	0.5	0.6	0.1	0.4	0.8	2.3	0.9	0.7	0	1.3	1.8	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0	0.5	0.1	0.3	1	0.1	0.2	0.2	0	0	21.5	27.7	5.3	34.1	15.3	25	12.4	25.4	27.4	5	0	0	0	0	0	24.4	0.4	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	114.4	0	0	0	0	0	0	0	0	0	18.6	0	0	0	0	4	0	0	0	0	0	0	0	0	0	Horizontal cells
ADGRG4	GPR112, PGR17, RP1-299I16	ENSG00000156920	Adhesion G protein-coupled receptor G4	Q8IZF6	X	136300963-136416888	G-protein coupled receptors, Plasma proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	21	intestine: 23.6	Cell type enriched	Detected in some	10	Horizontal cells: 39.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		TIME: 3.3									HPA035324	Uncertain											HPA035324: AB_10671512											unprognostic (3.40e-3)		unprognostic (7.68e-5)	unprognostic (7.61e-2)				0.4	0.1	0	0	0	0	0.3	0	0	0	12.9	0	0	7.1	0.7	1.1	0	0.9	0	0.1	0	0	0	0	0.2	0	0	0	1.1	0	0	0	0	0	0.1	0	0.5	0	0.1	0.1	0	23.6	0	0	0	0.4	0.2	0	0	0	0	0	0.8	0.6	0	0.1	0	0	0.1	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	3.3	0	0.8	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	39.7	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Horizontal cells
KCNJ6	BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2	ENSG00000157542	Potassium voltage-gated channel subfamily J member 6	P48051	21	37607376-38121345	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel	Congenital generalized lipodystrophy, Disease mutation, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.0;pituitary gland: 12.2	Cell type enriched	Detected in some	6	Horizontal cells: 232.0	Not detected	Not detected			Low region specificity	Detected in many			Group enriched	Detected in some	9	basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0	Lineage enriched	Detected in single	12	granulocytes: 4.2	Cell line enriched	Detected in some	7	LHCN-M2: 25.6	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (1.43e-1)	unprognostic (1.96e-1)	unprognostic (7.71e-2)	unprognostic (1.26e-3)	unprognostic (6.75e-2)	unprognostic (3.59e-1)	unprognostic (1.33e-1)	unprognostic (1.25e-1)	unprognostic (3.68e-1)	unprognostic (8.76e-2)	unprognostic (1.64e-2)	unprognostic (3.49e-1)	unprognostic (1.96e-10)	unprognostic (2.42e-1)	unprognostic (1.46e-1)	unprognostic (9.87e-2)	unprognostic (1.21e-1)	2	1.2	7.7	0.9	8.4	1	1.1	24	15.6	0.9	1.4	0.8	0	1.1	1.4	0.6	0.7	0.7	0.8	1.2	14.6	1.1	1.2	0.9	1	1.4	1.3	10.8	0.8	2.7	0.7	12.2	7.4	13.5	1.5	0.9	0	0.8	0.6	2.2	1.1	1.1	0.5	1.5	1.6	2.7	2	0.4	0	0.8	0	0.6	0.8	0.8	0.3	0.3	4.2	0.3	0.3	0.2	0	0	0	0.6	0.3	0	0.2	1.6	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0.2	0	0	0	0.1	0.2	0	0.8	1.4	0	0	0	2.9	0.1	25.6	0.1	0	0	0.3	0	2.5	0	0.1	0.8	3.6	0	1.5	0	0	0	0	0.1	0	0	3.8	0.3	0	0.1	0.2	3.8	1	0	0	0	0	4.2	0.3	3.6	0.2	0.1	0.1	0.2	0.1	0.1	0	0.3	0.1	0.2	2	0.3	0.2	0.3	0.1	0	7.7	8.4	24	15.6	14.6	1.1	1.3	10.8	13.5	0.4	0	0.6	0	0.4	0.1	31.8	21.5	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.3	0.2	0.4	0	0	0	232	39.7	0	0	0	0.6	0	3.3	0	0	0.9	1	0	0	0	2.3	0	0	0	1.1	0.1	0.2	0	0.1	0.3	Horizontal cells
CAMK2N2	CaM-KIIN	ENSG00000163888	Calcium/calmodulin dependent protein kinase II inhibitor 2	Q96S95	3	184259213-184261463	Predicted intracellular proteins		Protein kinase inhibitor		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	12	adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5	Cell type enriched	Detected in some	11	Horizontal cells: 58.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA050835, HPA075200	Approved		Supported	Nucleoplasm,Centrosome						Nucleoplasm, Centrosome		HPA050835: AB_2681253, HPA075200: 	unprognostic (7.28e-2)	prognostic favorable (9.77e-4)	unprognostic (1.24e-1)	unprognostic (4.69e-2)	unprognostic (1.32e-1)	unprognostic (6.09e-2)	unprognostic (2.20e-1)	unprognostic (1.29e-2)	unprognostic (1.88e-1)	unprognostic (4.21e-2)	unprognostic (5.98e-2)	unprognostic (9.72e-3)	unprognostic (5.17e-9)	unprognostic (3.47e-1)	unprognostic (2.39e-1)	unprognostic (1.07e-1)	unprognostic (1.76e-3)	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18	8.2	1.1	37	2	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0	1.3	0	1.2	1.2	0	0	0.5	0	0.2	0	0.3	0	11.3	0.2	1.4	0.6	0.4	0.4	1	0.3	4.2	2.7	2.8	0.4	0.5	0.4	2.8	0.2	5.5	1.5	0.7	0.5	1.5	9.3	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.7	0.4	1.9	0.6	0	0.3	0	3.3	0.4	6	0.1	0.1	8.1	0.2	3.7	19	5.5	1.6	0.6	2.2	20	4.3	1.8	0.5	0.1	0.1	6.1	0.1	0	20.8	9.1	1.9	3.3	2.2	3.3	2.7	4.8	1.2	1.7	0	0.2	0	0	0	0.3	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0	22.2	9.6	29.7	38.3	12.3	32.7	18	8.2	25.1	4.5	0	0	0	0	0	5.3	0.3	0	0	0	0	2	0	0	0	0.2	0	0	0	3.6	0	0	0.1	0	0	0	58.8	3.5	0	0	0.2	0	0	0	0	0	1.8	1	0	0	0	4.8	0	0.1	0.1	0.2	0	0	0	0	0	Horizontal cells
RET	CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51	ENSG00000165731	Ret proto-oncogene	P07949	10	43077027-43130351	Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion	Kinase, Transferase, Tyrosine-protein kinase	Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		parathyroid gland: 63.9	Cell type enriched	Detected in some	44	Horizontal cells: 74.7	Cancer enhanced	Detected in many		breast cancer: 11.0	Low region specificity	Detected in many			Cell type enhanced	Detected in some		non-classical monocyte: 6.7	Group enriched	Detected in many	13	dendritic cells: 2.1;monocytes: 6.7	Cell line enhanced	Detected in some		MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4	Low region specificity	Detected in many			Region enriched	Detected in all	6	midbrain: 95.5	CAB002581, HPA008356, HPA008495	Approved	Supported	Approved	Golgi apparatus,Plasma membrane,Cytosol		No			260000	Golgi apparatus, Cytosol	Plasma membrane	CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: 	unprognostic (7.94e-2)	unprognostic (3.68e-2)	unprognostic (4.49e-1)	prognostic unfavorable (5.02e-4)	unprognostic (1.15e-1)	unprognostic (9.13e-4)	unprognostic (1.27e-2)	unprognostic (3.62e-2)	unprognostic (2.86e-1)	unprognostic (2.01e-1)	unprognostic (1.54e-3)	unprognostic (4.43e-1)	unprognostic (9.35e-5)	unprognostic (1.64e-3)	unprognostic (8.28e-2)	unprognostic (3.67e-3)	unprognostic (2.02e-2)	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1	1.2	1.5	5.8	1	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2	0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0	6.7	0	0.3	0.4	0	0.1	0	0.5	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0.2	0	1.3	0	0	0	0	0	0	0	0	2.4	0	0	0.1	0	0	0	0	0	0	0	0	18	0	11.8	2.1	0	0	0	0	0	0	0	1.3	91.8	0	0	0	0.1	1.3	27.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	1.8	0	0.2	0	0	0.9	0	0	0	0	0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9	1.5	5.8	17.5	1.2	16.8	0	0	0.3	0	0.5	0.2	0.1	1.6	0	1.4	0	0	0	0	0	0	1.3	0.1	0	0	0.2	1.7	1	1.2	1.1	0.8	0.1	74.7	0	0	0	1.4	0.3	0	0	0	0.8	0.3	0	0	0	0	0.4	0	1.4	0.4	1.1	0.5	0	0	0	0.1	Horizontal cells
NAT16	C7orf52, FLJ39237	ENSG00000167011	N-acetyltransferase 16 (putative)	Q8N8M0	7	101170493-101180276	Predicted intracellular proteins		Acyltransferase, Transferase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6	Cell type enriched	Detected in some	45	Horizontal cells: 276.5	Cancer enhanced	Detected in some		melanoma: 2.1	Group enriched	Detected in many	4	amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4									HPA021918	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA021918: AB_1848922	unprognostic (4.32e-2)	unprognostic (1.75e-1)	unprognostic (2.69e-3)	unprognostic (4.58e-3)	unprognostic (2.93e-2)	unprognostic (2.61e-2)	unprognostic (6.14e-2)	unprognostic (1.40e-2)	unprognostic (2.25e-3)	unprognostic (2.35e-2)	unprognostic (4.23e-2)	unprognostic (2.62e-2)	unprognostic (5.53e-5)	unprognostic (7.65e-2)	unprognostic (2.48e-1)	unprognostic (5.02e-5)	unprognostic (1.59e-1)	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0	0	0.2	0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0	4.6	0	0	0.1	0	1.2	0.7	2.2	0.6	1.3	0.8	0	0.5	0	0.1	0.3	0	0	0.3	0.1	0	0	0	0.4	0.1	0	0.1	0.2	0.2	0.3	0.1	0	0	0	0	0	0.7	0	0	0.1	0.7	0.3	0	0	0.1	0.2	0	0.1	0	1.3	0.5	0.5	0.1	0.1	0.8	0	0.6	0.2	0.1	4.6	0.1	0.5	0.1	6.9	0	0.3	5.2	0.5	0.3	0	0	0.4	6.1	0.5	0.1	0.1	0	0.1	3.4	0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2	0	0	0	0	0	1	6.2	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	276.5	0	0	0	0	0	0	0	0	0	1.7	0.5	0	0	0	2.3	0	0	0	0	0	0	0	0	0.1	Horizontal cells
TBC1D16	FLJ20748, MGC25062	ENSG00000167291	TBC1 domain family member 16	Q8TBP0	17	79932343-80035848	Predicted intracellular proteins		GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Horizontal cells: 290.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	7	intermediate monocyte: 4.6;naive B-cell: 1.5;non-classical monocyte: 4.7	Group enriched	Detected in many	6	B-cells: 1.5;monocytes: 4.7	Cell line enhanced	Detected in many		ASC diff: 52.5;SK-MEL-30: 55.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA024482, HPA065839	Approved		Approved	Intermediate filaments						Intermediate filaments		HPA024482: AB_1857790, HPA065839: AB_2685566	unprognostic (4.53e-3)	unprognostic (1.36e-2)	unprognostic (1.80e-2)	unprognostic (2.06e-2)	unprognostic (4.92e-2)	unprognostic (7.21e-2)	unprognostic (1.05e-3)	unprognostic (1.72e-1)	unprognostic (5.92e-2)	unprognostic (1.13e-1)	unprognostic (2.23e-2)	unprognostic (9.76e-2)	unprognostic (1.52e-3)	unprognostic (3.02e-1)	unprognostic (1.28e-1)	unprognostic (3.65e-3)	unprognostic (3.99e-3)	32.2	8.1	10.1	7.8	18.2	1	32.6	25.5	11.2	10.7	8.6	6	28.4	7.5	11.9	20.9	9.8	12.8	9.3	10	8.1	7.8	18.1	13.2	8.5	13.7	8.7	5.6	11.8	18.7	9.3	6.6	7.1	8.2	17.3	5.8	15.4	25.5	24.2	4.5	15.8	7.9	10.8	8.1	8.7	7.6	5.2	9.5	2.7	9.7	7	3.9	9.2	14.6	1.5	0.3	0.1	4.7	0.1	0.5	0.3	8.2	7.9	12.3	14.4	52.5	27.7	2.3	4.8	4.8	3	3.5	14.8	2.9	0	3.4	8.1	5.8	2.6	12.9	4.5	2.3	0.4	6.1	0	3.6	6.8	8.9	0.1	1.1	31.1	8	6.6	4.8	4.9	13	5.6	1.9	5.6	5.7	5.1	2.1	0.7	14.7	10.8	4.3	6.9	7.8	4.7	3.6	10.2	12.6	16.3	4.3	12.1	55.7	8	7.9	3.7	8.7	10.7	7.7	8.4	4.2	17.2	3	0.9	4.6	3.1	13.5	0	0.3	0	0.1	4.6	0.5	0	0.1	0.2	0.3	1.5	0.2	0.3	0.1	0.1	4.7	0	0	0.3	10.1	18.2	25.5	11.2	8.1	7.8	8.7	5.6	8.2	9.5	0	9.3	0.8	3.6	4.8	6.6	7.2	17.8	2.7	2.3	7	9.8	5.2	8.3	13.8	1	9	3.2	0	19.3	1.1	12.8	9.6	7	16.2	3	290.8	30.5	15.4	43	1.6	5.5	3.8	72.6	1	6.4	21.5	16.9	2.8	7.4	10	7.4	6.5	10.5	0.2	3.4	4	1.6	3.8	5	5.7	Horizontal cells
ONECUT1	HNF-6, HNF6, HNF6A	ENSG00000169856	One cut homeobox 1	Q9UBC0	15	52756989-52791078	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	gallbladder: 40.1;liver: 59.9;pancreas: 46.3	Cell type enriched	Detected in some	17	Horizontal cells: 611.8	Group enriched	Detected in some	7	liver cancer: 2.9;pancreatic cancer: 0.8	Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 3.3;Hep G2: 4.0;MCF7: 5.1;RT4: 4.1;WM-115: 3.7	Region enhanced	Detected in single		hypothalamus: 1.1	Low region specificity	Detected in all			HPA003457	Enhanced											HPA003457: AB_1079525		unprognostic (5.12e-2)		unprognostic (2.45e-2)	unprognostic (2.64e-2)	unprognostic (4.82e-2)	unprognostic (9.19e-2)	unprognostic (7.05e-2)	unprognostic (5.73e-2)	unprognostic (2.59e-3)	unprognostic (1.03e-1)		unprognostic (1.70e-7)	unprognostic (9.76e-3)	unprognostic (2.11e-1)		unprognostic (1.17e-1)	0.1	0.1	0.5	0	0.1	1.2	0.1	0.9	0.3	0.1	0.1	0	0	0	0.1	0	0.1	0.1	40.1	0.1	0.2	0.2	0.1	59.9	0.1	0	0.1	0	0.1	46.3	0	0.1	0	1.4	0.1	0	3.5	0.1	0.1	0.1	0.2	0.1	0	0.2	0.1	0.1	2.4	0	0	0.1	0	0	0.1	0.1	0.1	0.2	0	0	0	0.1	0	0.3	1.2	3.3	1.5	0	0	1.5	0	0	0	0.1	1.4	0.2	2.1	0.1	0	0.1	0.2	0.2	0	0	0.3	0.2	0.2	1.4	4	0	0.7	0.1	0	0	0.1	0	0.1	0	1.1	0.3	0.4	0	5.1	0	0	2.5	0.4	0.3	0.9	0.3	0	0	4.1	1.7	0	0.6	0.1	0.4	2.9	1	0.2	0	2.1	2.7	0	0.4	0.3	0.1	0.3	0.4	0.4	3.7	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0.5	0.1	0.9	0.3	0.2	0.2	0.1	0	1.4	0	0	0	0	0	0	0.8	1	35.7	0	0	0	0	0	1.7	10.3	0.9	0	0	0	11.2	0	0	0	0	8.2	0	611.8	0	0	0.3	1.8	0	0	0	0	0	1	5.3	0	0	0	3.6	0	0.3	2.3	0.5	0	0	0	0	0	Horizontal cells
FRMPD4	KIAA0316, PDZD10, PDZK10	ENSG00000169933	FERM and PDZ domain containing 4	Q14CM0	X	12138466-12724523	Disease related genes, Predicted intracellular proteins			Disease mutation, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	brain: 16.4;parathyroid gland: 28.3	Cell type enriched	Detected in some	54	Horizontal cells: 158.9	Not detected	Not detected			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+ RasG12V: 4.3;LHCN-M2: 6.1;U-2197: 9.5;U-266/70: 8.7;U-266/84: 3.9	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (2.05e-1)	unprognostic (3.70e-2)			unprognostic (3.50e-2)	unprognostic (2.68e-3)		unprognostic (8.84e-2)	unprognostic (1.05e-2)	unprognostic (3.56e-2)	unprognostic (2.09e-2)	unprognostic (1.62e-2)	unprognostic (6.32e-2)	unprognostic (3.39e-1)	unprognostic (1.62e-1)	unprognostic (1.96e-1)	unprognostic (2.25e-1)	0.6	0.6	5.5	0.6	10.9	0.5	0.6	3.8	16.4	0.7	1.1	1	0	0.6	0.7	1	0.7	0.6	0.6	2.1	8.1	3.5	0.6	0.6	0.6	0.5	2.7	6.9	0.6	0.5	28.3	0.6	0.5	2.9	1.1	0.8	1.9	0.5	0.6	1.1	0.6	0.6	0.6	0.8	0.5	0.6	1	1.5	0	0.6	0	0.6	0.6	0.2	0	0	0	0	0	0	0	0	0.2	0.3	0	0.3	0.8	0	1.1	2.1	3.4	4.3	0	0	0	0	0.3	0	0	0	0	2.4	2.2	3.5	0	0.2	0	0.1	0	0	1.5	0	1.3	2.4	0.3	0	0	0	0.7	6.1	0	0	0	0.3	0	0	0	0	0	0	0.6	0	0	0	0	0	0.5	0	0	0	1	1.1	9.5	1	8.7	3.9	0	2.4	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.5	10.9	3.8	14.6	8.1	3.5	2.7	6.9	2.9	1.5	0	0	0	0	0.1	2.9	2.8	0	0	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	158.9	0	0	0	0	1.4	0	0	0	0	0.3	0	0	1.8	0	1.6	0	0	0	0.2	0	0	0	0	0	Horizontal cells
KCNAB3	AKR6A9, KCNA3B	ENSG00000170049	Potassium voltage-gated channel subfamily A regulatory beta subunit 3	O43448	17	7921859-7929803	Predicted intracellular proteins	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		brain: 36.1;endometrium 1: 17.2	Cell type enriched	Detected in some	5	Horizontal cells: 123.9	Low cancer specificity	Detected in many			Group enriched	Detected in all	5	cerebellum: 36.1;cerebral cortex: 31.6	Cell type enhanced	Detected in some		myeloid DC: 1.5;plasmacytoid DC: 1.7	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		REH: 14.9;SH-SY5Y: 8.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA077993			Approved	Mitochondria						Mitochondria		HPA077993: AB_2686872	unprognostic (3.02e-2)	unprognostic (5.59e-2)	unprognostic (6.95e-2)	unprognostic (2.62e-2)	unprognostic (6.13e-2)	unprognostic (5.84e-4)	unprognostic (2.19e-1)	unprognostic (5.72e-2)	unprognostic (8.50e-2)	unprognostic (8.55e-2)	unprognostic (3.27e-4)	unprognostic (7.47e-3)	unprognostic (3.03e-6)	unprognostic (2.12e-1)	unprognostic (5.00e-2)	unprognostic (4.97e-2)	unprognostic (9.54e-3)	1.4	0.7	4.2	2.7	5.2	5.5	1.2	36.1	31.6	1.8	1.4	0.8	0	1.3	17.2	2.2	0.8	3.5	2.1	0.7	4.7	2.9	1.7	1.1	1.5	3.8	2.4	6.3	2.1	1	0.8	4.9	1.6	5.9	2.3	2	3.8	1.3	1.4	1	3.3	1.9	11.4	5.2	2.6	2.2	1.7	1.9	0.8	1.6	0	3.3	1	1	0.1	1.7	0.5	0.2	0	0.7	0.1	1.3	1.1	5.5	1.4	0.6	1.4	2	4.9	3.1	4.2	4.8	0.7	0.3	2.2	0.3	0.8	0.2	0.4	1.5	0.7	6	1.8	2.3	0.7	0.9	0	5.1	0.2	3	2.2	1.6	4.6	0.2	0.2	0.3	6.1	0.5	0.3	0.7	1	0.8	2.6	0.8	0	0.7	14.9	1.5	0.6	0.5	1.7	0.3	8.1	0.4	0	0.9	0.2	1.4	0.1	0.3	0.7	2.8	1.1	0.4	1.1	1.2	1.2	2.1	3	1	0	0.2	0	0.5	0	0.7	0	0	0	1.5	0.1	0.2	0.2	0.5	0	0	1.7	0	0.1	4.2	5.2	36.1	31.6	4.7	2.9	2.4	6.3	5.9	1.9	3	2.4	0	0.6	0.5	22.9	0.8	0	0	1.2	0	3.9	0.2	0	0.5	0.3	0.1	0.4	0	0.5	0.2	1.1	0.6	1.1	0.2	0.7	123.9	0	0.6	0	0	1.7	0.8	0	1.8	0.3	12	0.5	0	0.7	0	6.3	0	0.3	3.1	1.5	0.4	0.1	0	0.2	0.1	Horizontal cells
MRAP	B27, C21orf61, FALP	ENSG00000170262	Melanocortin 2 receptor accessory protein	Q8TCY5	21	32291813-32314784	Disease related genes, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	9	adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6	Cell type enriched	Detected in some	4	Horizontal cells: 41.3	Not detected	Not detected			Region enriched	Detected in single	7	basal ganglia: 2.6	Cell type enhanced	Detected in many		NK-cell: 5.5	Low lineage specificity	Detected in many			Group enriched	Detected in some	6	Hep G2: 4.7;HSkMC: 5.4									HPA011024, HPA011093	Uncertain		Supported	Endoplasmic reticulum,Vesicles						Endoplasmic reticulum	Vesicles	HPA011024: AB_10599292, HPA011093: AB_10600889	unprognostic (1.38e-1)	unprognostic (1.55e-3)	unprognostic (1.53e-1)		unprognostic (1.11e-1)	unprognostic (9.53e-2)	unprognostic (1.31e-1)	unprognostic (1.38e-1)	unprognostic (2.27e-1)	unprognostic (1.18e-1)	unprognostic (1.80e-2)	unprognostic (4.12e-1)	unprognostic (6.30e-6)	unprognostic (3.32e-2)	unprognostic (2.37e-1)	unprognostic (1.18e-1)	unprognostic (5.76e-2)	28.3	52.7	0	1.6	2.6	0	68.6	0.3	0.1	0	3	0.7	0	0.1	0.1	0.2	0	0	0.4	1.6	0	0	0.1	0.6	0.2	1.8	0.2	0.1	0.8	0.1	0	0	1.1	0.3	0.1	0.1	0.2	1.7	0	0.9	0.2	1.1	0	0.3	0	0	0.2	0	0	0.2	0.8	0.1	0.6	4.3	1.8	1.5	0	0.5	5.5	1.8	0.1	0	0.4	0	0.1	0.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	4.7	0	0.9	0	5.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.2	0	0	0.2	0	0.1	0	0.7	0.1	0	0.1	0	0	0	0	0.4	0	0	0	0.4	0	0.9	0.5	0.7	1.8	0.7	1.2	0.5	1.4	0.8	1.6	0	5.5	0.3	1.5	1.8	0.1	0	2.6	0.3	0.1	0	0	0.2	0.1	0.3	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	10	0	0	0	0	0.1	0.2	0	0	1.3	0.1	41.3	0	0	0	4.6	0.6	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0.7	0	0	0	0	0	0	Horizontal cells
LRRN2	FIGLER7, GAC1, LRANK1, LRRN5	ENSG00000170382	Leucine rich repeat neuronal 2	O75325	1	204617170-204685733	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 20.3	Cell type enriched	Detected in some	5	Horizontal cells: 49.3	Group enriched	Detected in many	6	breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2	Low region specificity	Detected in all			Cell type enhanced	Detected in single		basophil: 1.7	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HEL: 7.1;NTERA-2: 14.3;RPMI-8226: 22.2;SuSa: 8.2;T-47d: 7.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029124	Uncertain		Approved	Endoplasmic reticulum						Endoplasmic reticulum		HPA029124: AB_10601545	unprognostic (2.16e-2)	unprognostic (1.93e-1)	unprognostic (1.35e-1)	prognostic unfavorable (2.59e-7)	unprognostic (1.40e-1)	unprognostic (1.17e-1)	unprognostic (2.89e-2)	unprognostic (1.21e-1)	unprognostic (4.63e-2)	unprognostic (1.15e-1)	unprognostic (1.52e-3)	unprognostic (1.16e-2)	unprognostic (1.68e-2)	unprognostic (1.43e-2)	unprognostic (7.33e-2)	unprognostic (1.88e-1)	unprognostic (1.59e-3)	4.9	6.6	11.8	3.7	16.5	2.4	3.3	9.7	20.3	1.9	7.9	5.3	1	1.9	3.9	0.8	2.4	10.2	6.1	6	11.7	12.8	7.3	0.7	2.5	2.9	6.3	13.8	3.3	1.4	19.1	9.7	1.3	8.1	1.6	7.5	12.2	2.8	3.7	2.2	0.7	3.3	9.9	3.1	6.3	1.4	3.8	6.1	3.2	2.8	0	1.3	2.1	1.5	0.4	0.1	1.7	0.3	0.7	0.8	0.2	0	3.3	2.7	0.1	0	0	0.3	0	0	0.1	0	0	0	0	0.2	0	0.1	0.3	0	0	0	0.1	0.1	7.1	0.5	0	0.2	0	0.7	0	0	0	0	0	0	0.1	0	0.3	0	0.7	1.1	0	14.3	0	0.1	0.2	0	22.2	0	0.1	1.9	0.3	4.4	0.1	0	8.2	7.9	0	0	0	3.2	0	0	0.5	0	0	0	0	0	1.7	0.3	0.2	0.1	0	0	0.3	0.1	0.1	0	0.4	0.1	0.2	0.7	0.7	0	0.1	0.8	0.2	11.8	16.5	9.7	15.7	11.7	12.8	6.3	13.8	8.1	6.1	0	0	0	0.5	0.3	4.6	1	0	0	0	1.8	2	0.1	0	2.7	0	0.7	1.7	0	0.8	0.1	1.1	0.3	0	0	5.3	49.3	10.9	4.9	0	0	0	0	0	0	1.9	3.9	3.3	0.3	0	2.7	0.9	0	0.4	0	0.2	0.1	0.3	0	0.7	0.3	Horizontal cells
CNTNAP2	Caspr2, KIAA0868, NRXN4	ENSG00000174469	Contactin associated protein like 2	Q9UHC6	7	146116002-148420998	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion		Autism, Autism spectrum disorder, Epilepsy, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.8	Cell type enriched	Detected in many	32	Horizontal cells: 974.1	Cancer enhanced	Detected in many		prostate cancer: 10.0	Low region specificity	Detected in many			Group enriched	Detected in some	31	memory B-cell: 1.8;naive B-cell: 6.1	Lineage enriched	Detected in single	48	B-cells: 6.1	Group enriched	Detected in some	4	AF22: 7.5;CACO-2: 6.3;NTERA-2: 11.2;SCLC-21H: 20.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA002739	Enhanced											HPA002739: AB_1078545	unprognostic (2.49e-2)	unprognostic (1.49e-2)	unprognostic (4.05e-1)	unprognostic (3.08e-3)	unprognostic (1.77e-1)	unprognostic (2.29e-1)	unprognostic (2.51e-2)	unprognostic (1.45e-2)	unprognostic (1.18e-1)	unprognostic (2.19e-1)	unprognostic (3.67e-2)	unprognostic (2.68e-1)	unprognostic (1.41e-1)	unprognostic (1.78e-1)	unprognostic (1.37e-1)	unprognostic (2.33e-1)	unprognostic (1.00e-3)	0.9	2	14	1.2	16.6	0.9	2.2	4.4	25.8	0.7	2.3	1.2	0	0.7	0.9	0.7	1.4	2.2	0.8	1	9.6	6.4	1	3.5	0.8	1.6	7.5	16.2	1.7	1.1	0.7	2.7	1.9	17	8.7	1.6	2.5	0.9	1	0.7	0.8	2	0.8	18.1	1.7	1.2	1.4	0.5	2.4	1.5	0	1.3	0.8	0.5	6.1	0	0.1	0	0	0	0.2	0	0	7.5	1.5	0	0	2.6	0	0	0	0	6.3	0.1	0	0	0.2	0	1.8	1.6	0.5	0	0	0	0.5	0	0.2	0	0	0	0.1	2.7	0	0	0	0	0	0	0	0	0	0	0	11.2	1.3	0	0	0	2.1	0	0	20.2	1	0	0	0	0.3	0.8	0	0	0	0.1	0	0	0.1	0	0.7	0	0	0	0	0	0	0	0	0	1.8	0	0	0	6.1	0	0	0.1	0	0	0	0	0.2	14	16.6	4.4	25.8	9.6	6.4	7.5	16.2	17	0.5	0	0	2	0.2	0.1	29.8	1.1	12.7	0	0	0	2	30	0	0.9	5.7	0	1.3	0	0.6	2.5	0.6	7.2	0	8.9	2.7	974.1	2.4	0	1.2	2.1	1.1	0.4	0	0	3.6	7	3.6	2.5	0	0.5	13.9	0	0.2	1.9	1.5	0	5.3	0	6.5	0.1	Horizontal cells
ZDHHC14	FLJ20984, NEW1CP	ENSG00000175048	Zinc finger DHHC-type containing 14	Q8IZN3	6	157381133-157678146	Enzymes, Predicted membrane proteins		Acyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Horizontal cells: 116.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		plasmacytoid DC: 4.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HDLM-2: 33.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA063754	Approved		Approved	Nucleoli,Mitochondria						Nucleoli	Mitochondria	HPA063754: AB_2685113	unprognostic (1.66e-2)	unprognostic (1.27e-2)	unprognostic (1.58e-2)	unprognostic (3.98e-2)	unprognostic (1.59e-1)	unprognostic (6.78e-3)	unprognostic (1.84e-1)	unprognostic (6.02e-2)	unprognostic (2.87e-2)	unprognostic (1.63e-1)	prognostic favorable (6.93e-4)	unprognostic (3.94e-2)	unprognostic (5.01e-3)	unprognostic (1.89e-1)	unprognostic (7.95e-2)	unprognostic (4.43e-1)	unprognostic (2.63e-1)	6.4	3.9	9	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5	1.5	4.2	0	0.1	0.4	0.9	0.4	1.7	1.8	0.6	2.6	1.4	1.1	5.9	2.7	2.5	1.9	1.7	2.2	1.3	4.3	0.9	2.2	3.7	0.9	1.5	1.5	1.8	33.4	2.1	8.4	0.7	1	1.9	1.1	1.9	0.7	1.6	2	0.8	1.7	2.9	1.9	6.7	3.2	1.1	1.1	0.7	2.8	1.1	3.4	2.2	0.1	0.3	2.5	4	0.7	4.3	1.3	3.2	2.1	2.3	1.2	0.3	1.3	4	2.9	2.1	5.7	3.5	0.7	0.8	0.6	1	3	3.2	0	0.1	0	0.5	0	0.9	1.5	0.4	0.4	0	0.8	0	0.3	0	0.4	0	4.2	0	0.4	9	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8	3	0	2.7	2.3	11.4	14.5	14.4	15.3	0	1.2	7	5.9	8.9	10	5.2	7.8	10.5	6.6	0	2.8	1.8	7.9	14.3	0	21.2	9.2	116	2.4	24.5	12.1	4	7.5	3.6	10.1	1.8	12.2	4.8	2.5	9.9	9.6	3.3	5.7	0	7.2	2.4	4.1	7.3	17.6	5	9.7	2.4	Horizontal cells
PLEKHD1	UPF0639	ENSG00000175985	Pleckstrin homology and coiled-coil domain containing D1	A6NEE1	14	69484692-69531551	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 7.4;brain: 16.0	Cell type enriched	Detected in some	5	Horizontal cells: 217.7	Low cancer specificity	Detected in single			Region enriched	Detected in many	7	cerebellum: 16.0	Cell type enriched	Detected in single	12	plasmacytoid DC: 7.4	Lineage enriched	Detected in single	12	dendritic cells: 7.4	Cell line enhanced	Detected in some		OE19: 2.8;SK-BR-3: 6.2;T-47d: 6.0;U-266/70: 2.8	Region enhanced	Detected in many		cerebellum: 33.7	Low region specificity	Detected in all			HPA051875	Uncertain											HPA051875: AB_2681648	unprognostic (8.73e-2)	unprognostic (4.64e-3)	unprognostic (3.73e-2)	unprognostic (4.03e-2)	unprognostic (7.58e-2)	unprognostic (3.15e-3)	unprognostic (1.44e-1)	unprognostic (1.64e-3)	unprognostic (3.28e-1)	unprognostic (1.83e-1)	unprognostic (4.56e-3)	unprognostic (1.22e-1)	unprognostic (5.49e-2)	unprognostic (8.08e-2)	unprognostic (2.28e-1)	unprognostic (2.74e-2)	unprognostic (1.42e-2)	0.3	0.3	0.4	0.1	1.5	1.1	1.4	16	2.2	0.5	0.2	0.5	2.5	0.3	0.2	4.2	0.2	0.2	0.2	0.3	0.6	0.5	1.8	0.1	0.4	2	0.8	0.1	0.2	0.5	4.5	0.6	0.1	1.4	0.2	0	4.1	3.9	4	0.2	2	0.2	0.1	0.6	0.4	0.3	1.8	0.4	0.8	4	0.1	0.5	0.2	0.2	0.2	7.4	0.6	0.1	0.1	0.1	0	0.3	0.3	0.5	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.7	0.5	0.5	0.1	0.2	0.5	0.8	0.1	0.1	0.5	0.4	0.1	0.4	0.1	0.1	0.5	0.8	0.1	0.3	0	0.1	0.1	0	0.3	0.2	1.2	0.1	0.9	0.4	0.4	0.7	2.8	0.1	0.3	0.1	0.2	0.5	0.5	0.8	1.9	0.2	6.2	0.1	0.2	6	0.2	0.2	0.3	0.8	0.4	0.3	2.8	0.6	0.3	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.2	0.1	0.1	0.6	0.1	0.1	7.4	0.1	0	0.4	1.5	16	2.2	0.6	0.5	0.8	0.1	1.4	0.4	0	8.2	0	1.7	0.3	46.2	0.8	0	1.4	3.4	0	3.9	0	3.3	0.1	0.3	0.7	0	0	0.2	0.1	0.4	1.4	1.1	0	0.1	217.7	0	0.6	0	0	0	0.6	0	1	0	1.7	0.2	0	0	0.1	5.3	0	0.4	0.5	0.2	0.3	0.1	0.5	0	0.6	Horizontal cells
TCERG1L	FLJ38950	ENSG00000176769	Transcription elongation regulator 1 like	Q5VWI1	10	131092391-131311721	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 9.7;thyroid gland: 24.1	Cell type enriched	Detected in some	10	Horizontal cells: 96.9	Cancer enriched	Detected in some	14	thyroid cancer: 20.3	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 9.4;NTERA-2: 1.4;RPMI-8226: 2.2;SuSa: 4.3;U-2 OS: 2.4	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA030816			Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA030816: AB_10601721	unprognostic (6.61e-2)	unprognostic (1.29e-1)	unprognostic (8.99e-2)	unprognostic (1.45e-2)	unprognostic (3.03e-1)	unprognostic (6.69e-2)		unprognostic (1.62e-1)	unprognostic (4.96e-1)	unprognostic (9.71e-2)	unprognostic (2.02e-1)	unprognostic (5.01e-2)	unprognostic (1.08e-5)	unprognostic (1.28e-1)	unprognostic (2.83e-1)	unprognostic (2.96e-2)	unprognostic (2.03e-1)	0.4	1.9	2.7	0.4	4.1	0.4	0.6	3	9.7	0.5	0.4	0	0	0.4	0.6	1.1	0.6	0.4	0.4	0.4	3.8	3.5	0.4	0.4	0.5	0.4	0.9	3.9	5.5	0.8	0.4	4.8	0.4	1.5	1.4	0.4	3.8	0.3	1.3	0.3	1.2	0.4	0.4	2.2	0.6	0.5	1.8	0	0.6	24.1	0	0.6	0.7	0.1	0	0.1	0	0	0	0.9	0	0	0	0	0	0	0	9.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	2.2	0	0	1.2	0	0	0	0	4.3	0.1	0	0	0	2.4	0	0	0	0	0	0.1	0	0	0	0	0	0.9	0	0	0	0.3	0.5	0	0	0	0.4	0	0	0	0.1	0	0	2.7	4.1	3	9.7	3.8	3.5	0.9	3.9	1.5	0	0	0	0	0.1	0.6	4.5	1.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.6	0.4	0.6	0	0	0	96.9	0	0	0	0	4.4	0	10.1	0	0	0.8	0.1	0	4.2	0	3.6	0	0	0.1	4.7	0.5	0.1	0	0	0	Horizontal cells
KCNG2	KCNF2, Kv6.2	ENSG00000178342	Potassium voltage-gated channel modifier subfamily G member 2	Q9UJ96	18	79863668-79900184	Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	4	brain: 5.3	Cell type enriched	Detected in some	16	Horizontal cells: 108.1	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0	Low region specificity	Detected in many			Region enriched	Detected in all	4	hippocampal formation: 31.7	HPA048628	Enhanced											HPA048628: AB_2680466	unprognostic (1.07e-2)	unprognostic (1.34e-2)	unprognostic (8.39e-2)	unprognostic (4.41e-1)	unprognostic (1.99e-1)	unprognostic (9.69e-2)	unprognostic (1.79e-1)	unprognostic (1.99e-1)	unprognostic (2.40e-1)	unprognostic (3.78e-1)	unprognostic (3.61e-3)	unprognostic (1.09e-1)	unprognostic (3.18e-5)	unprognostic (1.05e-1)	unprognostic (7.72e-2)	unprognostic (4.08e-2)	unprognostic (3.63e-2)	0.2	0.1	1.5	0.8	2.2	0.6	0	0.1	2.4	0	0.3			1.1	0.3	0	0.1	0	0	0	5.3	1	0.9	0.1	0.2	0.4	0		0.2	0	0	0.1	0.6		0	0		0.3	0	0	0.1	1.1	0	0.2	0.3	0.3	1.2			0		0	0.5	0	0.6	0.8	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0.1	0.3	0	0	0	0	0.4	0	0	0	0.9	0	0.9	0.3	0	0	0	0	0	0	0	0	0	0.2	0	3.5	0	0	0.7	0.3	0	0.3	0	0.4	0	0	0.2	0	0	0	0	0	0.6	0	1.1	0	0	0	0.7	0.1	0.1	1	0.3	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.2	0.8	0	0											0	0	0	0	0	0.5	0.6	0	0	0	0	0	4.2	0	0	0.2	0	0	0	0	6.7	0	0	0	0	1.2	108.1	0	0	2.4	0	0.3	0	0	0	0	0	0	0	0	0.2	0.9	0	0	0.3	2.1	0	5.3	0	0	0	Horizontal cells
NKPD1	FLJ33600	ENSG00000179846	NTPase KAP family P-loop domain containing 1	Q17RQ9	19	45149750-45158737	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	skin 1: 17.5	Cell type enriched	Detected in some	4	Horizontal cells: 4.8	Low cancer specificity	Detected in some							Cell type enhanced	Detected in single		naive CD4 T-cell: 1.8	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		hTCEpi: 4.0;SiHa: 3.5;U-266/70: 7.3	Low region specificity	Detected in some			Not detected	Not detected			HPA043339	Uncertain											HPA043339: AB_10962493	unprognostic (3.98e-2)	unprognostic (5.94e-2)	unprognostic (2.14e-1)	unprognostic (8.30e-4)	unprognostic (2.23e-1)	unprognostic (4.60e-2)	unprognostic (2.41e-3)	unprognostic (2.01e-2)	unprognostic (2.60e-1)	unprognostic (2.35e-2)	unprognostic (7.73e-4)	unprognostic (1.30e-1)	unprognostic (2.77e-5)	unprognostic (1.00e-1)	unprognostic (1.26e-1)	unprognostic (8.90e-2)	unprognostic (2.13e-1)	0	0.1	0	0	0.1	0.2	0.8	0.5	0.2	0.9	0			0	0	0.3	0.8	0.1	0	0	0	0.1	0	0	0	0	0		0	0	0	0.3	0		0.5	0		0.6	0.8	0.1	17.5	0	0	0	0	0	0.6			0.1		0	0	2.4	0.2	0.2	0.5	0.1	0.2	1.8	0	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0	0	0	0	1.5	0.4	0.3	0.7	0	0.1	0.4	0	0	0	0.5	0.6	1.5	0.1	0.1	0.1	0	0	0.2	4	0	0.1	0.1	0.1	0.2	0.4	0.7	0	1.1	0.7	0.5	0.3	1.8	0.4	0.1	0	0.3	0	0.1	0.6	0.3	3.5	1.8	0.1	0.5	1.3	0.3	0	0	0	0	0	7.3	1.7	0.3	0.1	0	0	0.5	0.1	0	0.1	0	0	0.1	0.5	0.6	0	0.2	1.8	0.1	0.4	0.2	0	0.2	0	0											0	0	0	0.2	0.1	0.8	0.4	0	0	0	0	0	0	0	0	0.5	0	0	0	0.2	0	0	0.1	0	0	0.1	4.8	0	0	0	0.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.7	0.2	1.1	0.1	0	0	0	Horizontal cells
ADGRB1	BAI1	ENSG00000181790	Adhesion G protein-coupled receptor B1	O14514	8	142449430-142545009	Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis	G-protein coupled receptor, Receptor, Transducer	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 27.4	Cell type enriched	Detected in some	9	Horizontal cells: 119.2	Cancer enhanced	Detected in many		glioma: 11.3	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 11.8;MCF7: 4.3;NB-4: 5.8;RPMI-8226: 16.3;U-2 OS: 11.2	Low region specificity	Detected in all			Low region specificity	Detected in all								Secreted in brain								unprognostic (9.57e-4)	unprognostic (1.28e-1)	unprognostic (3.87e-3)	unprognostic (8.50e-3)	unprognostic (9.98e-2)	unprognostic (5.87e-2)	unprognostic (3.39e-1)	unprognostic (2.14e-2)	unprognostic (2.76e-1)	unprognostic (2.55e-1)	unprognostic (6.48e-2)	unprognostic (3.43e-1)	unprognostic (7.30e-11)	unprognostic (6.27e-2)	unprognostic (7.42e-2)	unprognostic (4.52e-3)	unprognostic (3.29e-2)	1	3.4	13.6	1.4	18.1	0.9	1.1	5.4	27.4	2	1	3.1	0.1	1.4	1.8	2.3	0.9	1.4	0.9	0.9	11	11.9	1.1	0.8	1.2	1.6	8.7	9.2	1.6	1.1	0.9	2.7	2.5	9.1	1.3	0.9	0.9	2.6	1.9	0.7	3.1	1.4	1	2.3	3.7	1.5	2.1	3.2	0	0.9	0	1	0.9	0.4	0.2	0	0	0.1	0	0.6	0	0	0.1	0.1	11.8	0	0	0	0	0	0	0	0	0.1	0	1	0	0.1	0	0.9	0	0	0.8	0.4	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	4.3	0	5.8	1.8	0.2	0	0.1	0	16.3	0	0	3.1	3.1	0	0	0.2	0.2	0.1	0.3	0	0.1	11.2	0	0	0	0	0	0	0.2	0.8	0	0.1	0	0	0	0	0.1	0.6	0	0	0.2	0	0	0	0	0	0	0	0	13.6	18.1	5.4	19.5	11	11.9	8.7	9.2	9.1	3.2	0	0	0	0.2	0	13.1	5.3	2.5	0	0	0	0	0	1.7	0.4	0.2	0	0	0	0	0	0	0.2	0	0	0.1	119.2	0	0	0	0.6	0.3	0	0	1	0	3.8	0.1	0	12.7	0	0.6	6.5	0	0	0.9	0	0	0	0	0.1	Horizontal cells
KCNIP1	KCHIP1	ENSG00000182132	Potassium voltage-gated channel interacting protein 1	Q9NZI2	5	170353487-170736632	Predicted intracellular proteins, Transporters	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 31.2;epididymis: 27.8	Cell type enriched	Detected in some	4	Horizontal cells: 47.7	Cancer enriched	Detected in some	18	glioma: 22.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	23	RPTEC TERT1: 36.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA022864, HPA066717	Uncertain		Approved	Vesicles						Vesicles		HPA022864: AB_1858712, HPA066717: 	unprognostic (7.75e-5)	unprognostic (2.66e-2)	unprognostic (6.78e-2)	unprognostic (3.22e-4)	unprognostic (4.51e-2)	unprognostic (3.49e-1)	unprognostic (1.25e-2)	unprognostic (2.69e-1)	unprognostic (5.46e-2)	unprognostic (6.62e-3)	unprognostic (4.74e-2)	unprognostic (7.52e-2)	unprognostic (2.55e-1)	unprognostic (2.58e-2)	unprognostic (1.63e-1)	unprognostic (2.39e-1)	unprognostic (6.05e-2)	1.1	5.9	20.6	1.2	27.9	0.6	1.9	6.4	31.2	4	1	6	5.2	0.9	2.7	27.8	1	2.8	2.9	1.2	11.7	20.5	4.9	0.8	1.9	1.2	12.9	7.3	0.9	2.4	5.1	0.7	2.1	11.1	2.3	1.3	0.8	1.3	7.9	0.8	0.7	1.1	2.1	6.9	2.2	1.1	5.2	5.3	0	1.2	0	1.2	1.2	0.6	0	0	0	0	0	0	0	0	0	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	36.8	0	0.4	0	0	0	0	0.2	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.6	27.9	6.4	14.6	11.7	20.5	12.9	7.3	11.1	5.3	0	0	0	0.1	0.3	0.2	0.3	0	0	0	0	0	0	0	0.2	0.7	0.3	0	0	0	0	0.2	0	0	0	0.1	47.7	0	0	0	0	4.6	0	0	0	0	0.2	0	0	11	0	0.2	0	0	0	0	0	0	0	0	0	Horizontal cells
BEGAIN	KIAA1446	ENSG00000183092	Brain enriched guanylate kinase associated	Q9BUH8	14	100537147-100587413	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.9	Cell type enriched	Detected in many	15	Horizontal cells: 135.1	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Cell type enriched	Detected in some	5	eosinophil: 6.8	Lineage enriched	Detected in many	5	granulocytes: 6.8	Group enriched	Detected in some	7	HeLa: 21.8;SH-SY5Y: 53.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA002899			Approved	Nucleoplasm,Golgi apparatus,Cytosol						Nucleoplasm	Golgi apparatus, Cytosol	HPA002899: AB_1078277	unprognostic (2.98e-4)	unprognostic (2.75e-3)	unprognostic (2.66e-2)	unprognostic (2.66e-4)	unprognostic (2.77e-3)	unprognostic (1.93e-2)	unprognostic (5.16e-2)	unprognostic (6.35e-2)	unprognostic (3.83e-1)	unprognostic (4.33e-2)	unprognostic (4.15e-2)	unprognostic (5.47e-2)	unprognostic (1.59e-1)	unprognostic (9.01e-2)	unprognostic (3.11e-1)	unprognostic (2.75e-1)	unprognostic (2.60e-1)	1.8	5.5	16.4	1.1	10.8	6.4	1.5	24.9	21.6	1.3	1.3	0.9	0	4.6	2	1.8	1.4	3	2.5	1.5	15.3	7.1	0.9	0.8	1	1.3	4.4	6	3.5	13	2.3	8.2	3.1	3.6	2.6	0.9	2.1	2.8	2.7	0.9	1.3	3	1.7	2	3.3	1	2.6	1.4	5.4	1	0.4	1.3	0.8	0.6	0.6	1	6.8	1.5	0	0.4	0.1	0.3	1.3	0.7	4.5	0	0	0.1	0.1	0	0.2	0	0	0.4	0.1	0.2	0.2	1	0.1	0.2	0	0	0	0.4	2	21.8	0	0	0	0.1	0.1	0.1	0.3	0.5	0	0	0.3	0.2	0	0	1.7	0.1	0.6	0.5	0.1	0.7	0	0.1	2.7	0	0	1.2	53.1	1.2	0	1.2	0	0.3	5.4	0	0.1	1.6	0	0	0	0	0	3.8	1	0.1	1.3	0.1	6.8	0	1.5	0	0.6	0.4	0	0	0.2	0.1	0	0.6	0	1.4	1	0	0.1	16.4	10.8	24.9	17.3	15.3	7.1	4.4	6	3.6	1.4	0	1.1	0	1.4	2.2	1.5	1.4	0	0	1.2	0	0	0.1	0	1	0.3	0.6	0.7	0	6.9	0.2	1.4	0.5	9.2	0	0.2	135.1	0	0	0	0.6	1.7	0.7	1.7	1.8	0	0.7	4.1	0	6.3	0	2.4	0	0.3	0.9	0.4	1.8	0.1	0	0.2	0.3	Horizontal cells
KCNJ12	hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v	ENSG00000184185	Potassium voltage-gated channel subfamily J member 12	Q14500	17	21376197-21419872	FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in many	4	brain: 39.4;skeletal muscle: 47.8	Cell type enriched	Detected in some	7	Horizontal cells: 84.2	Low cancer specificity	Detected in many			Region enriched	Detected in many	7	cerebellum: 39.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3	Low region specificity	Detected in all							HPA027021	Approved		Uncertain	Nucleoplasm,Golgi apparatus,Cytosol						Golgi apparatus	Nucleoplasm, Cytosol	HPA027021: AB_10602912	unprognostic (3.81e-3)	unprognostic (2.69e-2)	unprognostic (8.60e-2)	prognostic unfavorable (7.84e-5)	unprognostic (2.29e-1)	unprognostic (1.73e-2)	unprognostic (3.80e-2)	unprognostic (1.54e-2)	unprognostic (4.39e-2)	unprognostic (4.91e-2)	unprognostic (8.12e-2)	unprognostic (1.16e-1)	unprognostic (4.22e-2)	unprognostic (2.23e-1)	unprognostic (1.51e-1)	unprognostic (5.90e-2)	unprognostic (9.70e-3)	1.2	1.3	1.9	0.9	2.9	0.7	0.9	39.4	5.8	1.2	0.8	1.1	0.5	0.5	0.8	1.4	1.5	2.1	0.7	5.1	0.9	1.4	1.2	0.5	1.3	0.4	1.3	3.4	0.7	0.5	10.6	0.7	0.7	4	0.9	0.6	1.7	0.6	0.9	47.8	6	0.6	1	0.9	1.3	0.9	1.3	0.9	0	1	7.5	1.1	0.8	1.5	0	0.9	0	0.5	0	0.1	0	0	1.1	0.4	2.2	0	0	0	0.2	0	0.1	0	0.2	0	0	3.6	0.1	0.2	0	0	0.1	0	0	0.1	0.2	5.9	0	0	0	0	0.1	0	0.6	0	0	0.2	0	0	0	0.4	0.1	0.1	0	1.5	0	6.3	0	1	1.6	0	0	7.3	0.4	3.7	0	1.5	8	0	0	2.8	0	0.5	6.3	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.9	0.1	0	1.9	2.9	39.4	5.8	0.9	1.4	1.3	3.4	4	0.9	0	0	0	0	1.3	0.8	12.5	0	0	0	1.8	0	0	1.7	0	0.4	1.4	0	0	0	0	2.1	0.2	0	0	0.2	84.2	1.2	5.5	0	0.2	6.9	0	0	0	0.4	11.2	0	0	3.9	0.6	1.4	0	0.5	0.5	1.3	1.9	0.1	0	0.6	0	Horizontal cells
C11orf87	LOC399947, LOH11CR1A, NEURIM1	ENSG00000185742	Chromosome 11 open reading frame 87	Q6NUJ2	11	109422120-109429114	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	brain: 32.3	Cell type enriched	Detected in some	17	Horizontal cells: 19.1	Cancer enhanced	Detected in single		glioma: 0.7	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	BJ hTERT+ SV40 Large T+: 4.0;fHDF/TERT166: 15.8;SCLC-21H: 4.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA034656	Approved											HPA034656: AB_10600788	unprognostic (5.42e-2)	unprognostic (2.09e-1)	unprognostic (2.28e-1)	unprognostic (8.55e-2)	unprognostic (3.87e-2)	unprognostic (1.85e-1)		unprognostic (1.63e-1)	unprognostic (1.55e-2)	unprognostic (1.62e-1)	unprognostic (2.44e-2)	unprognostic (2.45e-1)	unprognostic (5.28e-5)	unprognostic (8.38e-2)	unprognostic (9.65e-2)		unprognostic (2.72e-6)	0.7	1	5.8	0.7	18.1	0.7	0.8	2.7	32.3	2.3	0.8	1.5	0	0.8	2.2	1.2	0.8	1.1	0.7	0.7	8.3	3.8	0.8	0.7	0.7	0.7	2.5	12	0.7	0.7	0.7	0.3	0.8	11.1	0.9	0.7	0	0.8	0.8	0.7	0.8	0.7	0.8	1.2	2.2	0.8	0.8	0.1	0	0.7	0	0.7	0.7	0.2	0	0	0	0	0	0	0	0	0	0.7	0	0.3	0.6	0	0.1	0.2	4	1.9	0	0	0	0	15.8	0	0	0	0	1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	1	0	0	0	0	0	0	0	4.1	0	0	0	0	0	0	0	0	0.1	0	1.3	0.2	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	18.1	2.7	27.7	8.3	3.8	2.5	12	11.1	0.1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.1	0	0	0	0	0	0	0	0	0	0	0.1	0	1.1	0	0.3	0	0	0	0	0	0	0	0	0	Horizontal cells
FCHSD1	FLJ00007	ENSG00000197948	FCH and double SH3 domains 1	Q86WN1	5	141639302-141651419	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Horizontal cells: 50.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA043795	Approved		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA043795: AB_10963435	prognostic favorable (8.62e-4)	unprognostic (4.08e-2)	unprognostic (6.17e-2)	unprognostic (5.28e-2)	unprognostic (3.50e-3)	unprognostic (8.56e-3)	unprognostic (5.34e-2)	unprognostic (9.61e-3)	unprognostic (2.17e-2)	unprognostic (2.66e-2)	unprognostic (1.88e-3)	unprognostic (1.50e-2)	prognostic unfavorable (6.19e-6)	unprognostic (2.26e-1)	prognostic unfavorable (4.77e-4)	unprognostic (4.12e-3)	prognostic favorable (1.21e-4)	7.5	6.6	9.2	16.1	14.1	15.2	8.6	3	12.5	11.7	9.9	11.1	4.9	9.7	12.5	8.6	8.6	8.5	13.7	5.4	8.8	6.6	6.8	2.9	9.6	18.6	18.8	4.3	17.7	7.5	23.8	12.6	7.9	14.5	10	4.8	5.6	10.3	6.1	2.6	18.5	15.3	8.8	14.5	18.4	10.5	7.4	15.4	7.4	10.6	8.8	23.2	12.1	13.8	5.3	1.9	9.8	3	2.3	7.2	2.9	7.3	4.6	6.3	13.1	5.3	6.8	11	16	8.2	14.4	22.7	8.7	15.8	3.1	8	12.3	2.3	4.2	2	8.8	6.5	13	3.4	6.4	6.2	3.1	4.1	2	21.9	8.3	7.1	11.3	3.7	12.2	8.2	0.2	4	5.8	1.6	6.5	1.6	3.9	1.8	2.6	4.3	0	0	2.9	4.9	11	0.7	7.1	0.3	6	9.1	5	7.3	6.1	16.6	0.2	4	5.8	6.6	7	2.3	1.6	12.6	7.3	6.9	6.3	1.7	5.6	7	2	5.2	5.3	3.8	7.2	1.9	3	3.6	4.9	9.8	2.3	3	1.7	5	2.9	9.2	14.1	3	12.5	8.8	6.6	18.8	4.3	14.5	15.4	0	2.1	9	3.2	2.4	4.3	0.4	5.1	1.4	2.3	3.5	11.8	0.8	0	4	6.4	2.9	4.1	0	5.7	3.8	3.5	3	9.2	0.8	4.7	50.9	4.1	2.5	2.2	4.3	3.7	3.3	3.3	1.8	4.4	1.9	5.6	3.4	3.5	0.3	1.1	6.5	3.1	1.8	3.9	2.5	1.1	10.5	2.4	2	Horizontal cells
C20orf203	FLJ33706	ENSG00000198547	Chromosome 20 open reading frame 203	Q8NBC4	20	32631652-32673941	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 4.2;ovary: 2.1	Cell type enriched	Detected in some	4	Horizontal cells: 14.3	Not detected	Not detected							Cell type enriched	Detected in single	13	basophil: 4.2	Lineage enriched	Detected in single	13	granulocytes: 4.2	Cell line enhanced	Detected in some		HEL: 7.7;HMC-1: 5.4;NB-4: 2.3;U-266/70: 1.6																						unprognostic (6.24e-2)	unprognostic (3.39e-3)	unprognostic (8.39e-3)	unprognostic (2.06e-1)	unprognostic (1.19e-2)	unprognostic (6.70e-3)	unprognostic (7.53e-2)	unprognostic (2.52e-1)	unprognostic (5.39e-2)	unprognostic (6.22e-2)	unprognostic (1.00e-2)	unprognostic (1.39e-3)	unprognostic (1.25e-10)	unprognostic (3.37e-1)	unprognostic (2.04e-1)	unprognostic (1.23e-1)	unprognostic (7.46e-5)	0.1	0		0		0.3	0.3		1.1	0.2	0			0	1	1.1	0.4	1.1	0	0.5			0	0	0	0.4			2.1	0	0		0		0	0		1	0.5	0	0.8	0	0		0.3	0	0.3			0		0	0		0	0	4.2	0	0.1	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	7.7	0	0	0	0.4	5.4	0	0	0	0	0.1	0	0.3	0.3	0.1	0	0.1	0.3	2.3	0	0	0.1	0.3	0.1	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	1.6	0.2	0.4	0	1.1	0	4.2	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0											0	0	0	0.1	0.2	3.5	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	14.3	0	0	0	0	0.9	0	0	0	0	1.2	0	0	1.1	0	2.7	0	0.3	0	0.1	0.1	0	0	0	0	Horizontal cells
BRINP2	DBCCR1L2, FAM5B	ENSG00000198797	BMP/retinoic acid inducible neural specific 2	Q9C0B6	1	177171497-177282422	Predicted secreted proteins, Transporters	Cell cycle, Growth arrest			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	adrenal gland: 11.5;brain: 27.9	Cell type enriched	Detected in some	9	Horizontal cells: 14.3	Cancer enriched	Detected in some	5	glioma: 11.4	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 10.7;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.7;SH-SY5Y: 2.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA050681	Uncertain				Secreted in other tissues							HPA050681: 	unprognostic (7.78e-2)	unprognostic (4.49e-1)	unprognostic (2.53e-1)	unprognostic (1.57e-1)	unprognostic (2.57e-1)	unprognostic (2.43e-2)	unprognostic (1.77e-1)	unprognostic (5.77e-2)	unprognostic (1.23e-2)	unprognostic (1.95e-2)	unprognostic (2.20e-4)	unprognostic (8.95e-2)	unprognostic (1.78e-2)	unprognostic (2.60e-3)	unprognostic (1.17e-1)	unprognostic (2.60e-2)	unprognostic (4.82e-3)	0.4	11.5	12.2	0.3	8.2	0.3	1.9	0.4	27.9	0.3	0.4	0.6	0	0.3	0.5	0.9	0.3	0.6	0.4	0.4	7	6	0.3	0.4	0.3	0.3	4.5	3.6	0.3	0.3	0.3	2	1	0.8	0.4	0.3	0	0.3	0.4	0.3	0.3	0.3	0.4	1.5	0.5	0.3	1.8	0.3	0	0.3	0	0.3	0.3	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	10.7	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0.1	0	2.6	3	0	0	0	0	9.7	2.2	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.2	8.2	0.4	15.9	7	6	4.5	3.6	0.8	0.3	0	0	0	0	0	0.3	0.4	0	0	0	0	0	0	1.7	0	1.5	0	0	0	0	0	0	0	0	0	0.1	14.3	0	0	0	0.8	0.9	0	0	0	0	0.5	0.1	0	0	0	0.8	0	0	1.5	0.5	0	0	0	0	0	Horizontal cells
BTBD17	BTBD17A, LGALS3BPL, TANGO10A	ENSG00000204347	BTB domain containing 17	A6NE02	17	74356416-74361946	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	brain: 18.2	Cell type enriched	Detected in some	7	Horizontal cells: 27.0	Group enriched	Detected in some	11	glioma: 9.5;testis cancer: 1.9	Low region specificity	Detected in all			Cell type enhanced	Detected in single		naive CD4 T-cell: 1.4	Lineage enriched	Detected in single	14	T-cells: 1.4	Group enriched	Detected in some	20	AF22: 3.9;NTERA-2: 5.1;SCLC-21H: 15.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA025022	Approved				Secreted in brain							HPA025022: AB_2067352					unprognostic (2.63e-1)					unprognostic (2.77e-1)	unprognostic (4.82e-5)			unprognostic (3.89e-2)	unprognostic (2.55e-1)	unprognostic (9.89e-3)		0.4	1.5	5.4	0.4	5.1	0.4	0.4	5.6	18.2	0.4	0.4	2.7	0	1.2	0.4	0.4	0.4	0.4	0.4	0.4	3.7	5.7	0.4	0.4	0.4	0.4	3.8	1.8	0.4	0.4	0.4	0.2	0.4	6.1	0.4	0.4	0	0.4	0.4	0.4	0.4	0.5	0.4	3.7	0.6	1.4	0.5	2.2	0	0.6	0	0.4	0.4	0	0	0	0	0	0	1.4	0	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.1	0	0.1	0.4	0	0	0	0	15.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0.5	0	0	0	0	0	0	5.4	5.1	5.6	8.2	3.7	5.7	3.8	1.8	6.1	2.2	0	0	0	0	0	0.8	2.8	0	0	0	0	3.9	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	27	4.1	0	0	1.7	0	0	0	0	0	1.2	0	0	0	0	0.1	0	0	0.2	0.2	0	0	0	0	0	Horizontal cells
ONECUT3		ENSG00000205922	One cut homeobox 3	O60422	19	1752373-1780988	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		stomach 1: 9.4;testis: 3.8	Cell type enriched	Detected in some	4	Horizontal cells: 295.6	Group enriched	Detected in some	7	pancreatic cancer: 3.5;stomach cancer: 3.9					Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in some	8	HaCaT: 7.6;OE19: 10.1;PC-3: 17.1	Low region specificity	Detected in single			Region enhanced	Detected in some		hypothalamus: 1.3	HPA059936			Supported	Nucleoplasm						Nucleoplasm		HPA059936: AB_2684172	unprognostic (9.43e-2)	unprognostic (1.36e-1)	unprognostic (6.28e-2)	unprognostic (1.36e-3)	unprognostic (2.27e-1)	unprognostic (1.09e-2)	unprognostic (2.21e-1)	unprognostic (3.61e-3)	unprognostic (2.02e-1)	unprognostic (1.84e-1)	unprognostic (3.87e-2)	unprognostic (3.64e-1)	unprognostic (3.08e-10)	unprognostic (1.18e-1)	unprognostic (9.86e-2)	unprognostic (4.62e-1)	unprognostic (1.21e-2)	0	0	0	0	0.1	0.4	0	0	0	0	0			1.2	0	0.1	0.1	0	1.3	0.1	0	1.8	0	0	0	0	0		0	0.1	0	0	0		0	0		0	0	0	0.2	0.3	0	0.1	0.1	9.4	3.8			0.1		0	0	0	0.6	0.4	1.6	0.4	0.4	0.3	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	1.4	0.1	0.2	0	0	7.6	0	0	0	0	0	0.1	0.2	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0.2	0	0.1	0	0.2	0	10.1	17.1	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0.1	0	0.5	0.1	0	0.1	0	0.1	0	0	0	1.5	0.3	0.2	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.3	1.6	0.4	0.4	0.4	0.1	0											0	0	0	0.3	0.2	0.7	73.6	0	0	0	0	0	0	0	0	1.9	0	0	0	0.2	0	0.2	0.3	0	0	0.1	295.6	0	0	0	0.9	0	0	0	0	0	0.2	3.7	0	0.4	0	2.3	0	0	1.8	0.6	0.3	0	0	0	0.4	Horizontal cells
SCRT2	ZNF898B	ENSG00000215397	Scratch family transcriptional repressor 2	Q9NQ03	20	661596-676179	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	brain: 17.9;retina: 6.1	Cell type enriched	Detected in some	51	Horizontal cells: 57.2	Cancer enriched	Detected in single	5	glioma: 1.0	Group enriched	Detected in many	4	cerebellum: 8.8;cerebral cortex: 17.9	Cell type enriched	Detected in single	25	neutrophil: 2.4	Lineage enriched	Detected in single	25	granulocytes: 2.4	Group enriched	Detected in some	5	Karpas-707: 4.0;NTERA-2: 3.7;RPMI-8226: 8.1;SCLC-21H: 3.9;SH-SY5Y: 4.3	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA067697			Approved	Nucleoplasm						Nucleoplasm		HPA067697: AB_2685890					unprognostic (9.71e-2)					unprognostic (2.03e-1)	unprognostic (6.97e-2)			unprognostic (9.70e-2)	unprognostic (1.70e-1)			0.3	0.3	0.7	0.3	0.7	0.3	0.3	8.8	17.9	0.3	0.3	0.6	0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.6	0.3	0.3	0.3	0.3	1.9	0	0.3	1.3	0.3	0	0.4	3.2	0.3	0.3	6.1	0.3	0.3	0.3	0.3	0.3	0.3	1.1	0.6	0.3	0.7	0	0	0.3	0	0.3	0.3	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0.3	0	0	0	0	0	0	0	0	4	0	0	0	0	3.7	0	0	0	0	8.1	0	0	3.9	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0.7	0.7	8.8	17.9	0.7	0.6	1.9	0	3.2	0	0	0	0	0	0	0.8	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	57.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	Horizontal cells
PRRT4		ENSG00000224940	Proline rich transmembrane protein 4	C9JH25	7	128350325-128361685	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	bone marrow: 49.0	Cell type enriched	Detected in some	8	Horizontal cells: 9.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in single		naive CD4 T-cell: 1.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	5	SH-SY5Y: 72.0	Low region specificity	Detected in many			Not detected	Not detected			HPA046373, HPA052681	Uncertain		Approved	Nucleoplasm,Peroxisomes,Plasma membrane	Intracellular and membrane					Nucleoplasm	Peroxisomes, Plasma membrane	HPA046373: AB_2679642, HPA052681: AB_2681912	unprognostic (1.72e-1)	unprognostic (4.55e-2)	unprognostic (5.36e-3)	unprognostic (1.20e-4)	unprognostic (2.60e-1)	unprognostic (7.81e-2)	unprognostic (1.88e-1)	unprognostic (1.56e-1)	unprognostic (5.62e-3)	unprognostic (1.61e-1)	unprognostic (2.48e-4)	unprognostic (9.11e-2)	unprognostic (3.73e-4)	unprognostic (5.28e-3)	unprognostic (9.09e-2)	unprognostic (1.22e-2)	unprognostic (1.27e-2)	12.1	1.9	2	5.9	11.3	49	6.8	6.5	3.1	1.6	2.7	0.6	0	0.6	0.7	0.5	1.9	1	1.1	2.4	1.7	6.2	0.5	0.7	0.8	0.6	1.6	2.4	1	0.6	0.8	0	0.6	2.9	0.8	0.7	3.4	1.9	1.3	4.2	1.5	0.8	1	2.8	1.3	1.6	0.7	1.5	0.7	0.7	1.7	1	2	3.2	0	0.4	0.4	0.4	0	1.5	0.4	0	0	0.1	0.1	0.4	0	1.2	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	1.4	0	0	0	0	2.8	0	0.4	0	0	0	0	0	4.3	0	0	0	0.3	0.7	14.1	0.3	0	0	3.9	0.2	0.3	0	0	0.1	72	0.1	0	0.1	0.5	0	1.9	0	0	0.3	0.1	0	0	0	0	0	8.1	0	0	0.4	0	0.3	0	0	0	0.2	0.5	0	0	1.5	0.7	0.4	0	0	0.4	0	0.4	2	11.3	6.5	3.1	1.7	6.2	1.6	2.4	2.9	1.5	0	0	0	0	0.6	1.2	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.2	9.5	0	0	0	0	0.9	0	0	0	0	0.8	0	0	0	0	0.4	0	0.4	0	0.4	0.3	0.2	0	0	0	Horizontal cells
SHISA8	C22orf17, Orf26	ENSG00000234965	Shisa family member 8	B8ZZ34	22	41909554-41914667	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	brain: 42.2	Cell type enriched	Detected in some	114	Horizontal cells: 451.3	Low cancer specificity	Detected in some			Region enriched	Detected in many	15	cerebellum: 42.2	Cell type enhanced	Detected in single		memory B-cell: 1.7	Lineage enriched	Detected in single	17	B-cells: 1.7	Cell line enriched	Detected in some	7	HEK 293: 20.9	Group enriched	Detected in some	5	cerebellum: 8.7;olfactory region: 19.4	Group enriched	Detected in all	4	cerebellum: 61.4;olfactory region: 45.2	HPA059173	Uncertain											HPA059173: AB_2683938	unprognostic (8.76e-2)	unprognostic (2.98e-4)	unprognostic (1.03e-1)	prognostic favorable (2.76e-4)	unprognostic (4.42e-2)	unprognostic (1.45e-3)	unprognostic (4.40e-1)	unprognostic (1.16e-2)	unprognostic (2.13e-1)	unprognostic (2.57e-1)	unprognostic (1.45e-3)	unprognostic (2.16e-1)	unprognostic (1.12e-1)	unprognostic (8.59e-2)	unprognostic (2.60e-2)	unprognostic (6.22e-4)	unprognostic (7.84e-2)	0.1	9.4	0.5	1.6	0.5	0.2	0.1	42.2	2.7	0.2	0.2	0.2	0	0	0.1	0	0.4	0.2	0.3	0.3	0.5	0.2	0.2	0.1	0.1	3	0.3	1.7	0.1	0.1	0.1	0.8	0	2.2	0.2	0	1.5	1.8	0.2	0.8	0.5	0.8	0	0.3	2.7	0.7	0.2	0	0	0.1	0	3.8	0.4	0.1	1.7	0	0	0	0	0	0	0	0	0	0.4	0	0	1.4	0	0	0	0	0	0	0	0.9	0	0	0	0.2	0	0	0	20.9	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.2	0	0	1.1	0	0	0	0	0	2.9	0	0.3	0.2	0	0.2	0	0	0	0	0	0.5	2.2	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0.8	0	0	0	0	0	0	0	0	0.5	0.5	42.2	2.7	0.5	0.2	0.3	1.7	2.2	0	0	0	2.7	0	0	4	3.6	0	0	0	0	3.9	0	1.7	0	0.7	0	0	0	0	0	0	0.2	0	0	0	451.3	0	0	0	0.4	0	0	0	0	0	0.7	0	0	0.4	0	3.2	0	0	0.9	1.9	0	0	0	0	0	Horizontal cells
LHX1	LIM-1, LIM1	ENSG00000273706	LIM homeobox 1	P48742	17	36936785-36944612	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 15.0;kidney: 5.7;seminal vesicle: 7.1	Cell type enriched	Detected in some	9	Horizontal cells: 341.7	Cancer enhanced	Detected in some		ovarian cancer: 8.1					Cell type enhanced	Detected in single		memory CD8 T-cell: 1.1	Lineage enhanced	Detected in single		T-cells: 1.1	Cell line enhanced	Detected in some		HAP1: 6.3;HMC-1: 2.7;WM-115: 11.7	Region enhanced	Detected in many		cerebellum: 21.5	Region enriched	Detected in many	4	cerebellum: 20.4	HPA044307, HPA073521, HPA074382	Enhanced		Supported	Nucleoplasm,Nuclear membrane,Golgi apparatus						Nucleoplasm	Nuclear membrane, Golgi apparatus	HPA044307: , HPA073521: AB_2732226, HPA074382: 	unprognostic (3.86e-5)	unprognostic (1.64e-1)		prognostic unfavorable (3.63e-5)	unprognostic (3.85e-2)	unprognostic (1.06e-4)		unprognostic (2.67e-2)	unprognostic (2.72e-1)	unprognostic (1.52e-1)	unprognostic (4.20e-3)		unprognostic (1.74e-5)	unprognostic (1.33e-1)	unprognostic (8.62e-2)		unprognostic (3.05e-2)	0.1	0	0	0.1	0	0	0	15	0	0.2	0	0	1.8	0	0	0	0	0.5	0	0	0.1		5.7	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	7.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.3	0	0.1	0	0	1.1	0.1	1.3	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0	0.7	0	0.2	0	6.3	0	0	0	0.2	0	0	0.2	0	0	2.7	0	0.1	0	2	0.7	0	0	0	0	0	1.6	0	0.1	0.2	0	1.4	0	0	0	0	0	0.3	0	0	0	0	0.2	0.1	0.4	0	0	1.9	0	1.5	0	0	0	0.1	0	11.7	0	0	0	0	0	0	0.3	0	1.1	0	0	0	0	0.1	0	0	0	0.4	0.1											0	0	0	0	0	0.5	1.1	0	0	0	40.1	0	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0	0.1	341.7	0	0	0	0	0	0	0	0	0	0.2	0	0	0	9.2	1.7	0	0	0.9	1.2	0	0.3	0	0	0	Horizontal cells
